cephalosporin c has been researched along with Cronobacter Infections in 482 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 129 (26.76) | 18.7374 |
1990's | 50 (10.37) | 18.2507 |
2000's | 95 (19.71) | 29.6817 |
2010's | 178 (36.93) | 24.3611 |
2020's | 30 (6.22) | 2.80 |
Authors | Studies |
---|---|
Aitken, SL; Heil, EL; Monogue, ML; Pogue, JM | 1 |
Asch, J; Coombs, J; Ford, CD; Gouw, L; Hoda, D; Lopansri, BK | 1 |
Alby, K; Cowden, L; Cressman, L; Dumm, R; Glaser, L; Gross, R; Jaskowiak-Barr, A; Lautenbach, E; Mannathoko, N; Mokomane, M; Mosepele, M; Otukile, D; Paganotti, GM; Reesey, E; Richard-Greenblatt, M; Sewawa, K; Sharma, A; Smith, RM | 1 |
Jian, C; Li, Y; Ni, M; Ning, Q; Song, J; Tian, F; Wang, Y; Yu, B | 1 |
Boudour-Halil, D; Boutin, S; Chanthalangsy, Q; Heeg, K; Kocer, K; Nurjadi, D; Sähr, A | 1 |
Mo, SS; Nesse, LL; Norström, M; Ramstad, SN; Slettemeås, JS; Torp, M; Urdahl, AM | 1 |
Burnham, CD; D'Souza, AW; Dantas, G; Potter, RF; Wallace, MA; Yarbrough, ML | 1 |
Carbonnelle, E; Delerue, T; Le Monnier, A; Mizrahi, A; Morel, H; Pilmis, B; Zahar, JR | 1 |
Crook, DW; Fawcett, NJ; Llewelyn, MJ; Peto, L; Peto, TEA; Walker, AS | 1 |
Dramowski, A; Feasey, NA; Garner, P; Hamer, DH; Lester, R; Musicha, P; van Ginneken, N | 1 |
Bremell, D; Holmgren, A; Ljung, A | 1 |
Ciobotaro, P; Flaks-Manov, N; Flidel Rimon, O; Ghilai, A; Guri, A; Hoshen, M; Zimhony, O | 2 |
Buonomo, AR; Gentile, I; Maraolo, AE; Mazzitelli, M; Torti, C; Trecarichi, EM | 1 |
Alves, V; Cantón, R; Chaves, C; Diogo, J; Ferreira, R; García-Castillo, M; García-Fernández, S; Gonçalves, E; Melo-Cristino, J; Paixão, L; Pássaro, L; Pinto, MF; Ramalheira, E; Sancho, L; Silva, D; Vieira, AR | 1 |
Kharat, AS; Khobragade, K; Palwe, S; Periasamy, H; Veeraraghavan, B | 1 |
Duployez, C; Loiez, C; Migaud, H; Senneville, E; Wallet, F | 1 |
Harris, PNA; Henderson, A; Paterson, DL; Schembri, MA; Stewart, AG | 1 |
Froom, P; Hermush, V; Kasem, A; Salah, M; Shimoni, Z | 1 |
Arends, SJR; Duncan, LR; Flamm, RK; Pfaller, MA; Shortridge, D; Streit, JM | 1 |
Jeong, IS; Seo, SM | 1 |
Agunos, A; Boerlin, P; Calvert, J; Chalmers, G; Cormier, A; Moffat, J; Mulvey, MR; Reid-Smith, R; Ricker, N; Weese, JS | 1 |
Chen, X; Guo, S; Liu, D; Zhong, M | 1 |
Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A | 1 |
Arnold, SR; Bagga, B; Bice, T; Johnstone, K; Lee, KR; Shelton, CM; Stuart, CM; Stultz, JS | 1 |
Carevic, B; Carmeli, Y; Cohen-Percia, S; Fallach, N; Frenk, S; Harbarth, S; Hoffman, T; Kariv, Y; Klausner, J; Lellouche, J; Nutman, A; Temkin, E | 1 |
Dissaneevate, S; Janjindamai, W; Maneenil, G; Premprat, N; Thatrimontrichai, A | 1 |
Lee, D; Oh, JY; Park, HM; Sum, S | 1 |
Hesketh, T; Kritsotakis, EI; Wang, J; Zhou, M | 1 |
Hamprecht, A; Jazmati, N; Jazmati, T | 1 |
Abdallah, D; Dib, MJ; El Masri, H; Jadayel, M; Jisr, T; Lakkis, R; Moghnieh, R; Omar, T; Sinno, L; Zorkot, W | 1 |
Goldstein, E | 1 |
Hong, MY; Hsieh, CC; Hung, YP; Ko, WC; Lee, CC; Lee, CH | 1 |
Castanheira, M; Flamm, RK; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
Rodriguez-Bano, J; Tamma, PD | 1 |
Basumatary, MK; Bhattacharjee, A; Chakravarty, A; Choudhury, D; Dhar, D; Ingti, B; Maurya, AP; Mishra, S; Paul, D; Talukdar, AD | 1 |
Castanheira, M; Flamm, RK; Jones, RN; Mendes, RE; Pfaller, MA; Sader, HS | 1 |
Bias, T; Biason, K; El-Beyrouty, C; Gallagher, JC; Gardner, J; Harrington, N; Heil, E; Hiles, J; Huang, V; King, M; Kuriakose, S; McCoy, D; Richards, L | 1 |
Falagas, ME; Kofteridis, DP; Maraki, S; Mavromanolaki, VE; Perdikis, D; Samonis, G; Vardakas, KZ | 1 |
Antonelli, A; Arena, F; Bracco, S; Caltagirone, M; Giani, T; Luzzaro, F; Mauri, C; Nicchi, J; Nucleo, E; Pagani, L; Pantosti, A; Rossolini, GM | 1 |
Guo, X; Han, L; Sun, J; Wang, X; Xie, L; Zhang, F; Zheng, Q | 1 |
Altshuler, J; Fedorenko, M; Kim, SA; Paris, D | 1 |
Bonten, MJM; Bootsma, MCJ; Dautzenberg, MJD; Derde, LPG; Gniadkowski, M; Gurieva, T | 1 |
Hasso, M; Porter, V; Simor, AE | 1 |
Gomez-Simmonds, A; McConville, TH; Sullivan, SB; Uhlemann, AC; Whittier, S | 1 |
Bork, JT; Fowler, RC; Hanson, ND; Heil, EL; Johnson, JK; Leekha, S; Majumdar, A | 1 |
Castanheira, M; Flamm, RK; Pfaller, MA; Shortridge, D | 2 |
Crook, DW; Doi, Y; Feng, LQ; Huang, X; Li, HY; Lin, JL; Patil, S; Phan, HTT; Shen, C; Sheppard, AE; Stoesser, N; Tian, GB; Vihta, KD; Walker, AS; Xia, Y; Xing, Y; Zeng, KJ; Zhang, XF; Zhong, LL | 1 |
Livermore, DM; Mushtaq, S; Turner, SJ; Warner, M; Woodford, N | 1 |
Barbuddhe, SB; Bera, BC; Bhoyar, S; Chaudhari, SP; Choudhary, BK; Choudhary, M; Jain, A; Kale, SB | 1 |
Castanheira, M; Duncan, LR; Mendes, RE; Sader, HS; Shortridge, D | 1 |
Aitken, SL; Altshuler, J; Ericsson, CD; Guervil, DJ; Ostrosky-Zeichner, L; Wanger, A | 1 |
Boerlin, P; Chalmers, G; Dick, H; Reid-Smith, RJ; Shen, X; Slavic, D; Zhang, PLC | 1 |
Alfandari, S; Bertrand, X; Dumartin, C; Gauzit, R; Gbaguidi-Haore, H; Muller, A; Péfau, M; Rogues, AM | 1 |
Bunnell, KL; Danziger, LH; Harrington, AT; Wenzler, E | 1 |
Eumkeb, G; Evans, K; Hobbs, G; Nakouti, I; Teethaisong, Y | 2 |
Gastmeier, P; Kern, WV; Mischnik, A; Rohde, AM; Schwab, F; Seifert, H; Wiese-Posselt, M; Zweigner, J | 1 |
Bassetti, M; De Rosa, FG; Del Bono, V; Giacobbe, DR; Grossi, PA; Menichetti, F; Pea, F; Rossolini, GM; Tumbarello, M; Viale, P; Viscoli, C | 1 |
Bado, I; Caiata, L; Cordeiro, N; García-Fulgueiras, V; Outeda, M; Papa-Ezdra, R; Seija, V; Vignoli, R | 1 |
Bertrand, X; Bouiller, K; Bouxom, H; Fournier, D; Hocquet, D | 1 |
Ammerlaan, HSM; Bamberg, YRP; Bonten, MJM; Dorigo-Zetsma, JW; Kluytmans, JAJW; Kuck, EM; Prins, JM; Rottier, WC; Thijsen, SFT; van de Garde, EM; van der Linden, PD; van Hees, BC; van Werkhoven, CH; Verbon, A; Vlaminckx, BJM | 1 |
Brown, AC; Capers, C; Cardo, DM; Craig, M; Edwards, J; Huang, JY; Kainer, MA; Kallen, AJ; Mahon, G; Malik, S; McDonald, LC; Patel, J; Paul, P; Shugart, A; Slayton, RB; Srinivasan, A; Walters, MS; Weiner, LM; Wilde, N; Woodworth, KR | 1 |
Bowman, AS; Daniels, JB; Feicht, SM; Mathys, DA; Mollenkopf, DF; Stull, JW; Wittum, TE | 1 |
Dai, E; Duan, X; Fang, H; Feng, J; Gao, B; Luo, Y; Tong, Y; Wang, J; Xu, Y; Yin, Z; Zhan, Z; Zhang, Y; Zhou, D | 1 |
Akamatsu, N; Hasegawa, H; Kaku, N; Kosai, K; Matsuda, J; Morinaga, Y; Nishimura, F; Takeda, K; Uno, N; Yanagihara, K | 1 |
Ebihara, Y; Imai, K; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Sakai, J; Taji, Y; Tarumoto, N; Watanabe, N; Yamaguchi, T | 1 |
Pätäri-Sampo, A; Saxén, H; Vakkilainen, S | 1 |
Avril, C; Belmonte, O; Benoit-Cattin, T; Bertrand, X; Bonnin, RA; Cholley, P; de Montera, AM; Dortet, L; Filleul, L; Hocquet, D; Jaffar-Bandjee, MC; Leclaire, A; Lugagne, N; Martak, D; Miltgen, G; Naas, T; Roquebert, B; Subiros, M; Thouverez, M; Traversier, N | 1 |
Chang, WN; Chien, CC; Huang, CR; Lee, JJ; Lien, CY; Lu, CH | 1 |
Liu, J; Liu, L; Tang, M; Yu, J | 1 |
Bernards, AT; de Boer, MGJ; Lambregts, MMC; Visser, LG | 1 |
Bathoorn, E; Becher, D; Bonn, F; de Jong, A; Grasso, S; Nepal, S; Otto, A; Rosema, S; Rossen, JW; Stobernack, T; van Dijl, JM; Wedema, R; Zhou, K | 1 |
Buchs, NC; Carevic, B; Carmeli, Y; Cohen Percia, S; Dubinsky-Pertzov, B; Fallach, N; Fankhauser-Rodriguez, C; Harbarth, S; Kariv, Y; Klausner, J; Nutman, A; Radovanovic, I; Ris, F; Schiffer, E; Temkin, E | 1 |
Bonnin, RA; Dortet, L; Gauthier, L; Golse, N; Jousset, AB; Mihaila, L; Naas, T | 1 |
Bonten, MJM; Deelen, JWT; Rottier, WC; van Werkhoven, CH | 1 |
Balasubramanian, U; Bharadwaj, R; Gupta, A; Johnson, J; Kadam, D; Kagal, A; Kanade, S; Khadse, S; Kinikar, A; Kulkarni, V; Marbaniang, I; Mave, V; Nelson, G; Raichur, P; Robinson, ML; Sachs, J; Suryavanshi, N; Valvi, C; Zenilman, J | 1 |
Bassetti, M; Montravers, P | 1 |
Nariya, H; Shimamoto, T; Soliman, AM | 1 |
Anesi, JA; Bilker, WB; Dankwa, L; Garrigan, C; Han, JH; Lautenbach, E; Nachamkin, I; Omorogbe, J; Tolomeo, P; Wheeler, MK | 1 |
Goneau, L; Jarvis, M; Matukas, L; Romaschin, A; Tadros, M | 1 |
Kanlidere, Z; Karatuna, O; Kocagöz, T | 1 |
Armean, S; Behnke, M; Feihl, S; Gastmeier, P; Gebhardt, F; Hamprecht, A; Ihle, V; Kern, WV; Knobloch, JK; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, AM; Schröder, W; Schwab, F; Seifert, H; Tacconelli, E; Vehreschild, MJGT; Wiese-Posselt, M; Zweigner, J | 1 |
Hase, A; Horimoto, T; Matsuo, M; Ogasawara, J; Umeda, K | 1 |
Anesi, JA; Bilker, WB; Dankwa, L; Garrigan, C; Han, JH; Lautenbach, E; Nachamkin, I; Omorogbe, J; Tolomeo, P; Wheeler, M | 1 |
Asai, N; Hagihara, M; Kawamoto, Y; Koita, I; Koizumi, Y; Mikamo, H; Miyazaki, N; Ohno, T; Sakanashi, D; Suematsu, H; Yamada, A; Yamagishi, Y | 1 |
Epson, E; Horwich-Scholefield, S; Rizzo, K | 1 |
Bansal, S; Batra, N; Didwal, G; Gautam, V; Gupta, M; Kaushal, K; Ray, P | 1 |
Bernasconi, OJ; Büdel, T; Clément, M; Endimiani, A; Fehr, J; Hassan, NK; Hatz, C; Kuenzli, E; Mohammed, AH; Zinsstag, J | 1 |
Hächler, H; Nüesch-Inderbinen, M; Stephan, R; Zurfluh, K | 1 |
Bellon, O; Boutet-Dubois, A; Bouziges, N; Brieu-Roche, N; Davin-Regli, A; Dunyach-Remy, C; Gleize, E; Lamarca, R; Lavigne, JP; Le Coustumier, A; Lecaillon, E; Pantel, A; Prère, MF; Sotto, A; Villeneuve, L | 1 |
Bakthavatchalu, S; Mishra, T; Shakthivel, U | 1 |
Abgottspon, H; Hächler, H; Nüesch, HJ; Nüesch-Inderbinen, MT; Stephan, R; Zurfluh, K | 1 |
Powers, JH; Tamma, PD | 1 |
Carroll, KC; Cosgrove, SE; Girdwood, SC; Gopaul, R; Harris, AD; Roberts, AA; Tamma, PD; Tekle, T | 1 |
Blackburn, R; Hope, R; Johnson, AP; Livermore, DM; Reynolds, R; Woodford, N | 1 |
Hsueh, PR; Ko, WC; Lee, CC; Lee, NY; Li, CW | 1 |
Aitken, SL; Altshuler, J; Arias, CA; Esaian, D; Guervil, D; Papadopoulos, J | 1 |
Bhattacharya, D; Bhattacharya, H; Muruganandam, N; Roy, S; Sayi, DS; Sugunan, AP; Thamizhmani, R | 1 |
Bai, KJ; Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsu, CW; Hsueh, PR; Jean, SS; Ko, WC; Lam, C; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW | 1 |
Thomson, KS | 1 |
Amarsy-Guerle, R; Arlet, G; Bogaerts, P; Decré, D; Genel, N; Huang, TD; Jarlier, V; Jost, C; Podglajen, I; Raskine, L; Renvoisé, A | 1 |
Aubert, V; Baserni, MN; Jugo, MB; Villar, HE | 1 |
Graber, CJ; Nguyen, HM; Shier, KL | 1 |
Briggs, H; Burguete, SR; Cardile, AP; Herrera, M; Jorgensen, JH; Wickes, BL | 1 |
Chan, JF; Chen, JH; Cheng, VC; Ho, PL; Kwan, GS; Tai, JW; To, KK; Tse, H; Wong, SC; Yan, MK; Yuen, KY | 1 |
Kuti, JL; MacVane, SH; Nicolau, DP | 1 |
Chen, R; Chen, Y; Guo, L; Han, L; Han, X; Luo, Y; Tian, S; Yang, J; Ye, L; Zhao, J; Zhao, Q | 1 |
Cantón, R; García-Castillo, M; Gijón, D; Morosini, MI; Ruiz-Garbajosa, P; Tato, M; Valverde, A | 1 |
Castanheira, M; Jones, RN; Sader, HS; Williams, G | 1 |
Baghdady, N; Ferraro, MJ; Galar, A; Guzmán-Suarez, BB; Hooper, DC; Kubiak, DW; Marty, FM; O'Brien, TF; Siedner, MJ | 1 |
Hayakawa, K; Kirikae, T; Kubota, S; Kuroda, E; Kutsuna, S; Mezaki, K; Miyoshi-Akiyama, T; Nagamatsu, M; Ohmagari, N; Shimada, K; Sugiki, Y; Takeshita, N; Tojo, M | 1 |
Caron, F; Choplin-Renard, J; Etienne, M; Pestel-Caron, M; Van Elslande, H | 1 |
Adler, AL; Berry, JE; Hoffman, L; Oron, AP; Qin, X; Weissman, SJ; Wolter, DJ; Zerr, DM | 1 |
Bellenfant, F; Carbonnelle, E; Caumont-Prim, A; Chatellier, G; Fagon, JY; Grohs, P; Guerot, E; Gutmann, L; Kac, G; Meyer, G; Podglajen, I; Tillecovidin, B | 1 |
Hall, RM; Harmer, CJ | 1 |
Cloeckaert, A; Daminet, S; Doublet, B; Haesebrouck, F; Praud, K; Smet, A; Vaes, R | 1 |
Castanheira, M; Farrell, DJ; Flamm, RK; Jones, RN; Sader, HS | 1 |
Chan, MC; Chang, FY; Lee, Y; Lin, JC; Lin, TY; Yang, YS; Yeh, KM | 1 |
Ben Moussa, M; Lahlaoui, H | 1 |
Antonopoulos, IM; David-Neto, E; de Paula, FJ; Freire, MP; Guimarães, T; Moura, ML; Nahas, WC; Pierrotti, LC; Piovesan, AC; Spadão, F | 1 |
Blanchette, LM; Kuti, JL; Nailor, MD; Nicolau, DP | 1 |
Bhalodi, AA; Crandon, JL; Nicolau, DP; Williams, G | 1 |
Bonnet, R; Dalmasso, G; Delmas, J; Gibold, L; Robin, F; Serres, A | 1 |
Davis, SL; Kenney, RM; Tibbetts, RJ; Wagner, JL | 1 |
Ahmed, S; Ghosh, S; Hossain, MA; Kawaguchiya, M; Kobayashi, N; Mahmud, C; Nahar, K; Paul, SK; Urushibara, N | 1 |
Cao, B; Cheng, J; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Lu, J; Ni, Y; Shao, H; Shen, D; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Xu, Z; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
Ammerlaan, HS; Bamberg, YR; Bonten, MJ; Dorigo-Zetsma, JW; Rottier, WC; van der Linden, PD | 1 |
Crandon, JL; Nicolau, DP | 1 |
Berhin, C; Bogaerts, P; De Smet, B; Glupczynski, Y; Huang, TD; Jacobs, JA; Peetermans, WE; Phe, T; Vlieghe, ER | 1 |
Clark, SL; Eppes, CS | 1 |
Chow, DC; Fryszczyn, B; Hu, L; Nordmann, P; Palzkill, T; Poirel, L; Prasad, BV; Sankaran, B; Stojanoski, V | 1 |
Melchers, MJ; Mouton, JW; van Mil, AC | 1 |
Graber, CJ; Labreche, MJ; Nguyen, HM | 1 |
Arakawa, Y; Kawamura, K; Mura, T; Shibayama, K; Wachino, J | 1 |
López-Cerero, L; Pascual, Á; Rodríguez-Martínez, JM; Torres, E | 1 |
Bofarull, AM; Cantón, R; García-Castillo, M; Tato, M | 1 |
Chang, CM; Chen, PL; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC | 1 |
Crandon, JL; Ghazi, IM; Lesho, EP; McGann, P; Nicolau, DP | 1 |
Abdile, AA; Doi, Y; Harris, PN; Huh, K; Huxley, RR; O'Neal, CS; Pandeya, N; Paterson, DL; Paynter, S; Shen, AW; Talbot, TR; Wei, JY | 1 |
Ichiyama, S; Matsumura, Y; Nagao, M; Takakura, S; Tanaka, M; Yamamoto, M | 1 |
Bradley, JS; Capparelli, EV; Domonoske, C; Reed, MD; Shoji, K; van den Anker, JN | 1 |
Bowker, KE; MacGowan, AP; Noel, AR; Tomaselli, S | 1 |
Bork, JT; D'Angelo, RG; Heil, EL; Johnson, JK | 1 |
Bliss, C; Cloutier, DJ; Goldstein, EJ; Huntington, JA; Sakoulas, G; Steenbergen, JN; Umeh, O | 1 |
Frolova, LN; Kliasova, GA; Korobova, AG | 1 |
Estes, LL; Narayanan, PP; Patel, R; Rivera, CG | 1 |
Bastos, MS; Cardoso, CL; Garcia, LB; Menegucci, TC; Moreira, RRB; Tognim, MCB; Viana, GF | 1 |
Bernasconi, OJ; Carattoli, A; Endimiani, A; Hatz, C; Kuenzli, E; Perreten, V; Pires, J; Tinguely, R | 1 |
Behnke, M; Feihl, S; Gastmeier, P; Gebhardt, F; Hamprecht, A; Kern, WV; Knobloch, JK; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, AM; Schneider, C; Schröder, W; Schwab, F; Seifert, H; Tacconelli, E; Wiese-Posselt, M; Wille, T; Willmann, M; Zweigner, J | 1 |
Betts, J; Liakopoulos, A; Mevius, D; Oikonomou, O; Phee, LM; Wareham, DW | 1 |
Braun, T; Carmeli, Y; Fallach, N; Schechner, V; Schwartz, D; Schwartz-Neiderman, A | 1 |
Borgia, G; Gentile, I; Maraolo, AE | 1 |
Álvarez, MJ; López, IA; Martínez-Martínez, L; Mazarrasa, CF; Montes, JC | 1 |
Anesi, JA; Bilker, WB; Garrigan, C; Han, JH; Lautenbach, E; Nachamkin, I; Tolomeo, P; Wheeler, M | 1 |
Bercion, R; Bouchiat, C; Breurec, S; Cisse, MF; Garin, B; Glaser, P; Ka, S; Michel, R; Moquet, O; Ndiaye, O; Salord, H; Seck, A; Sire, JM; Sy, HS | 1 |
Baumert, P; Feihl, S; Gastmeier, P; Gebhardt, F; Gölz, H; Hamprecht, A; Kern, WV; Knobloch, J; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, A; Seifert, H; Tacconelli, E; Willmann, M | 2 |
Ahn, DR; Chang, J; Kim, Y; Oh, EJ; Park, KG; Park, MJ; Park, YJ; Yu, J | 1 |
Armstrong, ES; Bliss, CA; Cloutier, DJ; Mikulca, JA; Steenbergen, JN | 1 |
Bowker, K; MacGowan, A; Noel, A; Tomaselli, S | 1 |
Baumert, P; Feihl, S; Gastmeier, P; Gebhardt, F; Gölz, H; Hamprecht, A; Kern, WV; Knobloch, J; Kola, A; Mischnik, A; Obermann, B; Peter, S; Querbach, C; Rohde, AM; Seifert, H; Tacconelli, E; Willmann, M | 1 |
Livermore, DM; Mushtaq, S; Vickers, A; Warner, M; Woodford, N | 1 |
Bassetti, M; Castanheira, M; Duncan, LR; Pfaller, MA | 1 |
Atkinson, A; Bernasconi, OJ; Donà, V; Endimiani, A; Furrer, H; Hauser, C; Perreten, V; Pires, J; Rauch, A; Tinguely, R | 1 |
Ahmed, AM; Shimamoto, T | 1 |
Ikawa, K; Ikeda, K; Morikawa, N; Ohge, H; Sueda, T | 1 |
Lei, J; Lin, L; Ling, BD; Liu, G; Xie, YE; Zeng, Y | 1 |
Andes, DR; Craig, WA | 1 |
Fernandes, R; Freitas, JM; Gestoso, A; Prudêncio, C; Santos, P | 1 |
Chen, Z; Deng, Y; Huang, L; Liu, J; Lü, D; Ma, J; Wang, M; Wang, X; Xu, X; Zeng, Z; Zhang, Y | 1 |
Deal, EN; Micek, ST; Reichley, RM; Ritchie, DJ | 1 |
Martínez-Lamas, L; Romero-Jung, PA; Treviño, M; Varón, C | 1 |
Cockerill, FR; Kohner, PC; Patel, R; Robberts, FJ | 1 |
Herrera, M; Jorgensen, JH; Lewis, JS; Towne, TG; Wickes, B | 1 |
Chang, SC; Lauderdale, TL; Wang, JT; Yang, JL | 1 |
Chang, EP; Chen, TL; Chiang, DH; Lin, ML; Liu, CY; Wang, FD | 1 |
Deb, M; Gaind, R; Mohanty, S; Ranjan, R | 1 |
Chung, DR; Joung, MK; Kang, CI; Ko, KS; Lee, JA; Moon, SY; Peck, KR; Song, JH | 1 |
Adams, C; Clair, J; Mac Aogáin, M; Mooij, MJ; O'Gara, F | 1 |
Bouza, E; Cercenado, E; Coronel, P; Cuevas, O; Gimeno, M; Marín, M | 1 |
Boileau, P; Coquery, S; Guibert, M; Traoré, P; Zupan-Simunek, V | 1 |
Armand-Lefèvre, L; Aubron, C; Bronchard, R; Chaari, A; Lucet, JC; Montravers, P; Régnier, B; Wolff, M | 1 |
Barin, A; Bolourchi, M; Farzaneh, N; Gharagozlou, F; Hovareshti, P; Kasravi, R; Seifi, HA | 1 |
Beckius, ML; Glasser, JS; Markelz, AE; Mende, K; Murray, CK; Zera, WC | 1 |
Crandon, JL; Furtado, GH; Nicolau, DP; Williams, G; Wiskirchen, DE | 1 |
Cui, S; Hu, C; Jin, S; Li, J; Lin, L; Luo, Y; Ma, Y; Ran, L; Zhang, W | 1 |
Rogers, TR; Walsh, F | 1 |
Parta, M | 1 |
Alvarez-Espejo, T; Asensio, A; Bishopberger, C; Calbo-Torrecillas, F; Campayo, J; Canton, R; Fernandez-Crehuet, J; Hernandez Navarrete, M; Ramos, A; Vaque-Rafart, J | 1 |
Briales, A; Diaz de Alba, P; Fernández-Cuenca, F; Fernández-Echauri, P; Pascual, A; Rodríguez-Martínez, JM | 1 |
Brown, D; Castanheira, M; Critchley, I; Drusano, GL; Grasso, C; Jones, RN; Kulawy, R; Liu, W; Louie, A; Thye, D; Vanscoy, B; Williams, G | 1 |
Conte, D; Dalla-Costa, LM; Maia, FV; Monteiro, CL; Nogueira-Miranda, Kda S; Palmeiro, JK; Reason, IT | 1 |
Belomestnykh, N; Bennett, GJ; Ceglowski, B; Rauch, BJ; Saltman, RL; Schukken, YH; Sharkey, HL; Thomas, MJ; Zadoks, RN; Zurakowski, MJ | 1 |
Agüero, J; Aracil, B; Borrell, N; Bou, G; Coelho, A; Conejo, MC; Fernández, A; Gozalo, M; Larrosa, N; Miró, E; Navarro, F; Oliver, A; Oteo, J; Pascual, A; Pomar, V; Rodríguez-Baño, J; Villar, M | 1 |
Andre, C; Arpin, C; Boukadida, J; Coulange-Mayonnove, L; Dubois, V; Messadi, AA; Quentin, C; Thabet, L; Yassine, H | 1 |
Cornaglia, G; Kocsis, B; Kocsis, E; Koncan, R; Lanzafame, P; Mazzariol, A | 1 |
Dahyot, S; Mammeri, H | 1 |
Crandon, JL; Housman, ST; Keel, RA; Nicolau, DP; Williams, G | 1 |
De Jesús, A; Hernández, L; Marcano, D; Torres, L | 1 |
Borgundvaag, B; Croitoru, K; Gnanasuntharam, P; Le, B; Leung, W; Malhi, G; McGeer, AJ; Nguyen, GC; Silverberg, MS; Steinhart, AH; Thanabalan, R; Weizman, AV; Willey, BM | 1 |
Freeman, JT; Gamble, GD; Holland, DJ; McBride, SJ; Nisbet, MS; Taylor, SL; Williamson, DA | 1 |
Assoumou, MC; Boreux, R; De Mol, P; Gangoué-Piéboji, J; Lonchel, CM; Meex, C; Melin, P | 1 |
Cheong, HS; Chung, DR; Kang, CI; Ko, KS; Peck, KR; Song, JH | 1 |
Andremont, A; Arlet, G; Bernède-Bauduin, C; Guillemot, D; Papy, E; Schlemmer, B; Sollet, JP; Thiébaut, AC | 1 |
Bonten, MJ; de Smet, AM; Kesecioglu, J; Oostdijk, EA | 1 |
Daniels, TL; O'Neal, CS; O'Neal, HR; Talbot, TR | 1 |
Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Ni, Y; Tang, HJ; Toh, HS; Wang, JH; Xu, Y; Yu, KW | 1 |
Dortet, L; Nordmann, P; Poirel, L | 1 |
Bosques, F; Camacho-Ortiz, A; Garza-González, E; González, GM; Llaca-Díaz, JM; Muro, S; Rositas, F | 1 |
Assoumou, MC; Boreux, R; De Mol, P; Gangoué-Piéboji, J; Lonchel, CM; Melin, P | 1 |
Barl, P; Bedenić, B; Plečko, V; Sardelić, S; Uzunović, S; Vraneš, J | 1 |
Altouvas, G; Mamali, V; Pitiriga, V; Pournaras, S; Themeli-Digalaki, K; Tsakris, A; Tziraki, M; Zarkotou, O | 1 |
Deliolanis, I; Giamarellou, H; Hatzaki, D; Katsarolis, I; Lambri, N; Lebessi, E; Nikolopoulos, GK; Poulakou, G; Souli, M | 1 |
Kimura, S; Kitazawa, T; Koga, I; Makita, E; Matsunaga, N; Okugawa, S; Ota, Y; Seo, K; Yoshino, Y | 1 |
Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC | 1 |
Ghebremedhin, B | 1 |
Bonomo, RA; Droz, S; Endimiani, A; Hilty, M; Hujer, AM; Mühlemann, K; Perreten, V; Seiffert, SN; Sendi, P | 1 |
Kimouli, M; Kristo, I; Pitiriga, V; Poulou, A; Pournaras, S; Tsakris, A; Zarkotou, O | 1 |
Aller, SC; Chusid, MJ | 1 |
Kim, BN; Kim, MN; Kim, YS; Lee, SO; Ryu, J; Woo, JH | 1 |
Barnes, BJ; Micek, ST; Polish, LB; Ritchie, DJ; Wiederhold, NP | 1 |
Ciccaglione, D; Fadda, G; Fiori, B; Nicoletti, G; Posteraro, B; Romano, L; Sanguinetti, M; Spanu, T; Zanetti, S | 1 |
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL | 1 |
Burgmann, H | 1 |
Harris, AD; Kim, PW; Morris, JG; Perencevich, EN; Roghmann, MC; Strinivasan, A | 1 |
Kim, BN; Kim, YS; Ryu, J; Woo, JH | 1 |
Buescher, ES; Chambers, PA; Heritage, J; Tyndall, C | 1 |
Berezin, AG; Iakovlev, SV; Romashov, OM; Sidorenko, SV | 1 |
Bell, JM; Jones, RN; Turnidge, JD | 1 |
Azi, M; Boussemart, T; Manouana, M; Perez, JM; Piet-Duroux, S; Port-Lis, M | 1 |
Brown, DF; Carmeli, Y; Livermore, DM; Paterson, DL; Quinn, JP; Yu, VL | 1 |
Arlet, G; Barnaud, G; Benzerara, Y; Gravisse, J; Labia, R; Raskine, L; Sanson-Le Pors, MJ | 1 |
Choi, MK; Fish, DN; Husain, M; Jung, R | 1 |
Lin, D; von Baum, H; Wendt, C | 1 |
Bertrand, X; Lopez-Lozano, JM; Muller, A; Talon, D | 1 |
Laufs, R; Mack, D; Noor, D; Sobottka, I; Stürenburg, E | 1 |
Bradley, SF; Loeb, MB; McGeer, A; Moss, LM; Sandoval, C; Simor, AE; Walter, SD | 1 |
Ben Abdallah, H; Ben Redjeb, S; Boutiba-Ben Boubaker, I; Ghozzi, R; Kamoun, A; Mamlouk, K | 1 |
Byeon, JH; Hong, JY; Kim, YK; Lee, HJ; Pai, H | 1 |
Baba, H; Kawamura, K; Nada, T; Ohkura, T; Ohta, M; Torii, K | 1 |
Bahar, G; Eraç, B; Gülay, Z; Mert, A | 1 |
Ben Meriem, C; Ghedira Besbes, L; Guediche, MN; Messaoudi, A | 1 |
Bonten, MJ; Florijn, A; Fluit, AC; Nijssen, S; Schmitz, FJ; Verhoef, J | 1 |
Choe, KW; Kang, CI; Kim, EC; Kim, HB; Kim, SH; Lee, KD; Oh, MD; Park, WB | 1 |
Bonten, M; Florijn, A; Fluit, A; Nijssen, S; Top, J; Willems, R | 1 |
Deshpande, LM; Jones, RN; Pottumarthy, S; Sader, HS | 1 |
Bonomo, RA; Paterson, DL | 1 |
Di Conza, JA; Gutkind, GO; Méndez, E; Mollerach, A; Mugna, V; Radice, M; Truppia, LA | 1 |
Chuang, YM; Ho, YC; Hsueh, PR; Teng, LJ; Tseng, SP | 1 |
Baraniak, A; Bossaert, L; Demey, HE; Gniadkowski, M; Goethaert, K; Goossens, H; Ieven, M; Jansens, H; Jorens, PG; Lammens, C; Van Herck, K; Van Looveren, M | 1 |
Heesemann, J; Hoffmann, H; Roggenkamp, A; Stürenburg, E | 1 |
Bindu, D; Kumar, CP; Menon, T; Nalini, S; Thirunarayan, MA | 1 |
Attias, D; Henshke-Bar-Meir, R; Raveh, D; Rudensky, B; Schlesinger, Y; Yinnon, AM | 1 |
Paterson, DL | 2 |
Hope, R; Johnson, AP; Livermore, DM; Potz, NA; Warner, M | 1 |
Matsumoto, T; Muratani, T | 1 |
Cauda, R; D'Inzeo, T; Fadda, G; Fiori, B; Posteraro, B; Sanguinetti, M; Santangelo, R; Spanu, T; Tumbarello, M | 1 |
Adeyi, B; DiNubile, MJ; Friedland, IR; Ginanni, JA; McCarroll, KA; Stratchounski, LS; Wood, CA; Woods, GL; Yakovlev, SV | 1 |
Avlamis, A; Daikos, GL; Markogiannakis, A; Papaparaskevas, J; Papapareskevas, J; Petrikkos, G; Stefanakos, G; Zissis, NP | 1 |
Ayala, JA; Bauvois, C; Di Conza, J; Galleni, M; Gutkind, G; Power, P; Rodríguez, MM | 1 |
Deal, EN; Dunne, WM; Kollef, MH; Micek, ST; Reichley, RM; Ritchie, DJ | 1 |
Apfalter, P; Assadian, O; Daxböck, F; Hirschl, AM; Makristathis, A; Rotter, ML | 1 |
Ge, Y; Kaniga, K; Livermore, DM; Mushtaq, S; Warner, M | 1 |
Bonten, MJ; Bootsma, MC; Diekmann, O; Fluit, AC; Nijssen, S | 1 |
Denton, M | 1 |
Lei, J; Lin, L; Ling, BD; Liu, G; Xie, YE; Zeng, Y; Zhang, X | 1 |
Alcalá, L; Bouza, E; Cercenado, E; Goyanes, MJ; Insa, R; Morente, A | 1 |
Cornaglia, G; Garau, J; Livermore, DM | 1 |
D'Andrea, MM; Mugnaioli, C; Rossolini, GM | 1 |
Kahlmeter, G | 1 |
Hope, R; Livermore, DM; Mushtaq, S; Warner, M | 1 |
Giamarellou, H | 1 |
Hammami, A; Ktari, S; Mahjoubi, F; Mezghani, S; Mkaouar, D; Znazen, A | 1 |
Guo, ZL; He, LX; He, ZG; Liang, YJ; Ren, T; Zhai, XB; Zhang, L; Zheng, YH | 1 |
Gustafsson, I; Hallgren, H; Ripa, T | 1 |
El-Khodery, SA; Osman, SA | 1 |
Brennan, SS; Evans, M; Mayer, AD; Pickford, IR; Pollock, AV | 1 |
Cherubin, CE; Corrado, ML; Landesman, SH | 1 |
Axelrod, JL; Kochman, RS | 1 |
Barriere, SL; Pons, VG; Wilson, CB | 1 |
Gardner, S; Schreiber, M; Shulman, ST; Yogev, R | 1 |
Carter, MJ; Fisher, JF; Parsons, J; Rissing, JP | 1 |
Buntin, DM; Crutcher, N; Eaglstein, NF; Hester, MG; Lober, CW; Marley, WM; Marlowe, SL; Rosenberg, EW | 1 |
Eaglstein, NF; Hernandez, AD; Marley, NF; Marley, WM; Rosenberg, EW | 1 |
Decazes, JM; Meulemans, A; Regnier, B; Vachon, F; Witchitz, JL; Wolff, M | 1 |
Carson, HB; Heller, AS; Koch, TB; Schentag, JJ; Walczak, P | 1 |
Borderon, JC; Huguet, B; Prieur, D | 1 |
Bastin, R; Bure, A; Frottier, J; Vilde, JL | 1 |
Canton, P; Dureux, JB; Gérard, A; Roche, G; Weber, M | 1 |
Gajdos, P; Goulon, M; Pilliot, J | 1 |
Auboyer, C; Bouletreau, P; Bui-Xuan, B; Flandrois, JP; Motin, J; Reverdy, ME | 1 |
Butzler, JP; Clumeck, N; George, G; Jaspar, N; Rapin, M; Van Laethem, Y; Vanhoof, R | 1 |
Acar, JF; Guibert, J; Justin, C; Kitzis, MD | 1 |
Borderon, JC; Boulard, P; Despert, F; Grenier, B; Laugier, J; Santini, JJ | 1 |
Aufrant, C; Aujard, Y; Beaufils, F; Bingen, E; Blum, C; Lambert-Zechovsky, N; Mathieu, H | 1 |
Gérard, A; Paris, J; Paris, JC | 1 |
Kermarec, J; Sauvaget, J | 1 |
Hyams, KC; Mader, JT; Parks, DH; Pollard, RB; Reinarz, JA; Thomson, PD | 1 |
Verbist, L | 1 |
Gootz, TD; Martin, RR; Moellering, RC; Perkins, RL; Sanders, CC; Sanders, WE; Strike, DG | 1 |
Neu, HC | 1 |
Ehrenkranz, NJ; Hoffman, TA | 1 |
Crawford, ED; Plimpton, HW | 1 |
Bégué, P; Brun, Y; Fleurette, J; Floret, D; Monnet, P; Safran, C | 1 |
Guggenbichler, JP | 1 |
Stille, W | 1 |
Knothe, H | 1 |
Schaad, UB | 2 |
Andreoni, G; Angela, GC; Bendiscioli, L; Braida, M; Bramato, C; Capra, E; Cignolo, G; di Nola, F; Eandi, M; Lollini, P; Musso, E; Pizzo, L; Salassa, B; Soranzo, ML; Spezia, C | 1 |
Berkowitz, FE; Colsen, P; Raw, K | 1 |
Hellum, KB; Ingram, PM; Svarva, PL; Walstad, RA | 1 |
Ingham, HR; Selkon, JB; Snow, MH; Wardle, JK | 1 |
Foord, RD | 1 |
Childs, SJ; Douthit, MB; Gentry, LO; Madsen, PO | 1 |
Bebear, C; de Barbeyrac, B; Quentin, C; Savary, N; Texier, J | 1 |
Butzler, JP; Clumeck, N; Gordts, B; Jaspar, N; Van Laethem, Y | 1 |
El-Sadr, W; Maslow, MJ; Pollock, AA; Press, RA; Rahal, JJ; Richmond, AS; Rosenberg, A; Silverman, D; Simberkoff, MS | 1 |
Modde, H | 1 |
Goldstein, E; Hoeprich, PD; Nolan, SM; Olson, DA | 1 |
Gorrochategui, M; Holt, RJ; Perez, C | 1 |
Carrizosa, J; Kaye, D; Kobasa, WD; Snepar, RA | 1 |
Levy, RL; Saunders, RL | 1 |
Kemp, R | 1 |
Brion, N; Carbon, C; Kecir, M | 1 |
Bouvet, E; Regnier, B; Schlemmer, B; Vachon, F; Witchitz, J; Witchitz, S | 1 |
Abergel, P; Reignier, B; Vachon, F; Witchitz, J; Witchitz, S; Wolff, M | 1 |
Granich, GG; Krogstad, DJ; Murray, PR; Niles, AC | 1 |
Bhaduri, S; Heimpel, H; Krieger, D; Kurrle, E; Pflieger, H | 1 |
Beckwith, DG; Jahre, JA | 1 |
Cunha, BA; Ristuccia, AM | 1 |
Deguchi, K; Fujimaki, Y; Icikawa, G; Kawamura, S; Oguri, T; Sugita, R | 1 |
Chrzanowska, I; Prusek, W; Springer, L; Zygmunt, A | 1 |
Birnbaum, J; Celozzi, E; Miller, AK; Pelak, BA; Stapley, EO | 1 |
Azzoni, P | 1 |
Preheim, LC; Sanders, WE | 1 |
Kondo, M; Tsuchiya, K | 1 |
Jones, RN; Packer, RR | 1 |
Weinstein, AJ | 1 |
Gibbs, RS; Huff, RW | 1 |
Fairley, KF; Graham, I; Miles, H; Nankervis, A; Pavillard, R; Shaw, P; Whitworth, JA | 1 |
Cappelletty, DM; Kang, SL; Palmer, SM; Rybak, MJ | 1 |
Acolet, D; Ahmet, Z; Houang, E; Hurley, R; Kaufmann, ME | 1 |
Kaufmann, ME; Mentis, AF; Tzelepi, E; Tzouvelekis, LS | 1 |
Low, DE; Scriver, SR; Toye, BW | 1 |
Ramphal, R; Wolff, MA; Young, CL | 1 |
Shlaes, DM | 1 |
Bailey, C; Gascoyne-Binzi, DM; Hawkey, PM; Heritage, J; Hibbert-Rogers, LC; Lewis, IJ; Todd, N | 1 |
Cohen, SH; Iglesias, T; Inciardi, JF; Jacobson, KL; King, JH; Lippert, WE; VanCouwenberghe, CJ | 1 |
Rothman, AL; Spaulding, AC | 1 |
Leggiadro, RJ | 1 |
Burman, LG; Haeggman, S; Tullus, K; Walder, M | 1 |
Kotis, E; Nikolaidis, P; Sofianou, D; Tourkantonis, A; Tsakris, A | 1 |
Kessler, RE; Sanders, WE; Tenney, JH | 1 |
Chang, SC; Chen, YC; Hsieh, WC; Luh, KT; Shih, CC | 1 |
Bolooki, H; Fernandez, L; Holland, F; Jacobs, J | 1 |
Aller, R; Boixeda, D; De Argila, CM; de Luis, DA; Ruiz Del Arbol, L | 1 |
Beauchamp, D; Bergeron, MG; Morin, NJ; Simard, M; Turcotte, A | 1 |
Caillon, J; Jacolot, A; Louchahi, K; Mimoz, O; Padoin, C; Petitjean, O; Samii, K; Tod, M | 1 |
Eppes, S; Salen, PN | 1 |
Carton, D; Gamiz-Jimenez, J; Renders, F; Robberecht, E; Van Winckel, M; Vlaminck, H | 1 |
Jepsen, CF; Klebe, TM; Prag, J | 1 |
Schmid, P; Shpigel, NY | 1 |
Black, D; Fritsche, TR; Gautom, RK; Limaye, AP | 1 |
Medeiros, AA | 1 |
Bauernfeind, A; Gniadkowski, M; Jungwirth, R; Mikiewicz, B; Pałucha, A; Schneider, I | 1 |
Jacolot, A; Mimoz, O; Padoin, C; Petitjean, O; Samii, K; Tod, M | 1 |
Horii, T; Ichiyama, S; Kobayashi, M; Ohta, M; Sato, K | 1 |
Budanov, SV | 1 |
Jones, RN | 1 |
Acar, J | 1 |
McCoy, GC; Morin, DE; Shanks, RD | 1 |
Berneman, ZN; Bruyneel, P; Goossens, H; Mebis, J; Meeus, I; Schroyens, W; Sion, JP; Van Droogenbroeck, J | 1 |
Burman, LG; Finnström, O; Haeggman, S; Isaksson, B | 1 |
Hidri, N; Jacolot, A; Leotard, S; Mimoz, O; Nordmann, P; Petitjean, O; Samii, K | 1 |
Barroso, H; Duarte, A; Freitas-Vieira, A | 1 |
Buxbaum, A; Georgopoulos, A; Graninger, W | 1 |
Cahen, P; Honderlick, P; Saheb, F | 1 |
Del Valle Vázquez, L; Delgado Zamora, R; Elgorriaga Guillén, LJ; Fernández Arance, P; Gutiérrez Caracuel, J; Ortega Calvo, M | 1 |
Clemente González, C; García Bragado, F; Ruiz Aguirre, J; Vilert Garrofa, E | 1 |
Bowers, JL; Cay, O; Clouse, ME; Nosaka, T | 1 |
Deblangy, C; Decré, D; Fichelle, A; Joly-Guillou, ML; Kosmann, MJ; Lucet, JC; Pernet, M; Régnier, B | 1 |
Inoue, M; Kuga, A; Okamoto, R | 1 |
Bollet, C; Bornet, C; Bosi, C; Davin-Regli, A; Pages, JM | 1 |
Jacolot, A; Leotard, S; Louchahi, K; Mimoz, O; Nordmann, P; Padoin, C; Petitjean, O | 1 |
Boulétreau, P; Mohammedi, I; Vieille, E | 1 |
Guichenez, G; Guichenez, P; Joomaye, Z; Marciano, J; Oziol, E; Ygout, JY | 1 |
Deville, JG; Fattal, O | 1 |
Desai, N; Hill, RL; Philpott-Howard, J; Shannon, K; Verma, A | 1 |
Bailly, P; Bertrand, X; Mulin, B; Talon, D; Thouverez, M | 1 |
Arlet, G; Barnaud, G; Labia, R; Philippon, A; Raskine, L; Sanson-Le Pors, MJ | 1 |
Kan'ovska, E; Khitsova, S; Rosmanova, R; Sredkova, M; V'lkova, A | 1 |
Demesova, D; Hromec, J; Krcmery, S | 1 |
Koeck, JL; Rousseau, JM; Soullié, B; Villevielle, T | 1 |
Calil, R; Marba, ST; Tresoldi, AT; von Nowakonski, A | 1 |
Cornaglia, G | 1 |
Carmeli, Y; Cosgrove, S; Eliopoulos, GM; Harris, A; Kaye, KS | 1 |
Berger, R; Gruenewald, T; Leibovici, L; Milo, G; Paul, M; Pitlik, SD; Samra, Z; Yahav, J; Yehezkelli, Y | 1 |
Campillo, SB; Dupeyron, C; Leluan, G; Mangeney, N; Richardet, JP | 1 |
Carmeli, Y; Harbarth, S; Harris, AD; Samore, MH | 1 |
Fung, CP; Ho, MW; Liu, CY; Wang, FD | 1 |
Amir, J; Harel, L; Straussberg, R | 1 |
Burgess, DS; Lewis, JS; Nathisuwan, S | 1 |
Chanawong, A; Hawkey, PM; Heritage, J; M'Zali, FH; Xiong, JH | 1 |
Ambrose, PG; Garvey, MJ; Jones, RN; Owens, RC | 1 |
Chen, YS; Fung, CP; Liu, CY; Wong, WW; Yu, KW | 1 |
Butzler, JP; Clumeck, N; Vanhoof, R; Vanlaethem, Y | 1 |
Goering, RV; Sanders, CC; Sanders, W | 1 |
Humbert, G; Leroy, A | 1 |
Hoyme, U; Madsen, PO | 1 |
Benzer, H; Coraim, F; Koller, W; Lackner, F; Pichler, H; Rotter, M; Stanek, G | 1 |
Goldberger, MJ; Neu, HC; Parry, MF | 1 |
Naumann, P; Rosin, H | 2 |
Fass, RJ; File, TM; Gardner, WG; Perkins, RL; Prior, RB; Ruiz, DE; Slama, TG; Tight, RR; Warner, JF | 1 |
Cunningham, FG; Gilstrap, LC; Kappus, SS | 1 |
Hashimoto, T; Hayashi, S; Narita, H; Tsuruga, N; Yura, J | 1 |
Di Lena, C; Jolascon, A; Marchi, K; Pinto, L; Vitale, R | 1 |
Bergmann, R; Mitsuhashi, S; Wahlig, H | 1 |
Geheber, CE; Guest, BS; Kolb, LD; Stone, HH | 1 |
Levine, LR; McCain, E | 2 |
Bodey, GP; Ketchel, S; Rodriguez, V | 1 |
Lentnek, AL; Weinstein, AJ | 1 |
Donovan, TL; Gordon, RO; Nagel, DA | 1 |
Baquero, F; Fernández-Rodríguez, A; Pérez-Díaz, JC; Picazo, JJ; Reguera, JA | 1 |
Douglas, JM; Mangione, EJ | 1 |
Pechère, JC; Vladoianu, IR | 1 |
Chow, JW; Fine, MJ; Hooper, DC; Johnson, MP; Miyashiro, DK; Quinn, JP; Ramphal, R; Shlaes, DM; Wagener, MM; Yu, VL | 1 |
Sanders, CC | 2 |
Smith, DL | 1 |
Araki, H; Minami, S; Watanabe, Y; Yasuda, T | 1 |
Ukhin, AV | 1 |
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
Besbes, M; Brun-Buisson, C; Legrand, P; Lemaire, F; Meakins, JL; Montravers, F; Rauss, A; Richard, C; Soussy, CJ | 1 |
Abruzzo, GK; Bland, JA; Fromtling, RA; Gadebusch, HH; Gilfillan, EC; Hadley, SK; Pelak, BA; Weissberger, BA | 1 |
Noe, HN; Whitfield, JD | 1 |
Gaston, MA | 1 |
Nicolle, LE | 1 |
Burdeska, A; Costa, E; Follath, F; Frei, R; Meyer, J; Thommen, A | 1 |
Brunel, D; Guenounou, M; Nauciel, C; Outin, HD; Paul, G; Philippon, A; Pilliot, J; Ronco, E | 1 |
Cheng, DL; Fung, CP; Juang, YC; Liu, CY; Wang, LS | 1 |
Inoue, M; Mitsuhashi, S; Utsui, Y | 1 |
Mansa, B; Søgaard, P; Togsverd, E | 1 |
Araki, H; Minami, S; Mitsuhashi, S; Saikawa, I; Takai, A; Watanabe, Y; Yasuda, T | 1 |
Bach, AW; Collins, FJ; Foster, RJ | 1 |
Weinstein, RA | 1 |
Claesson, BE; Filipsson, S; Holmlund, DE; Mätzsch, TW; Wählby, L | 1 |
Berche, P; Gaillard, JL | 1 |
Cooke, RW; Damjanovic, V; Modi, N | 1 |
Akl, BF; King, RM; Kuritsky, JN; Lapham, SC; Palmer, DL | 1 |
Gould, IM; Wise, R | 1 |
Guenthner, SH; Norris, SM; Wenzel, RP | 1 |
Haas, CE; Paladino, JA | 1 |
Saslaw, S | 1 |
Black, HR; Griffith, RS | 1 |
Martin, WJ; Washington, JA; Yu, P | 1 |
Barrett, FF; Ewing, WH; Finland, M; Kass, EH; Wilfert, JN | 1 |
Birk, RJ; Ritts, RE; Washington, JA | 1 |
Steinitz, H | 1 |
Bertrand, A; Despaux, E; Janbon, F; Jourdan, J | 1 |
Betourné, C; Tancrède, C | 1 |
Gómez Francisco, A | 1 |
Gadebusch, HH; Miraglia, GJ; Renz, KJ | 1 |
Celozzi, E; Hendlin, D; Kong, Y; Miller, AK; Pelak, BA; Stapley, EO | 1 |
Louria, DB; Mead, PB | 1 |
Brewin, AW; Bruyn, HB | 1 |
Benhassine, M; Mered, B; Rahal, K | 1 |
Bullock, WE | 1 |
Bodner, SJ; Koenig, MG | 1 |
Plotkin, SA | 1 |
Andriole, VT; Lyons, RW | 1 |
Oclander, G | 1 |
Brunner, H; Gelzer, J; Hess, R; Konopka, EA; Kradolfer, F; Sackmann, W; Zak, O | 1 |
Geddes, AM; Munro, JF; Murdoch, JM | 1 |
Clark, H; Turck, M | 1 |
Foord, RD; Kirby, SM; Muggleton, PW; O'Callaghan, CH; Ryan, DM | 1 |
40 review(s) available for cephalosporin c and Cronobacter Infections
Article | Year |
---|---|
Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections | 2020 |
Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.
Topics: Africa South of the Sahara; Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli; Humans; Prevalence; Sepsis | 2020 |
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Observational Studies as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Soft Tissue Infections; Tazobactam; Urinary Tract Infections | 2020 |
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam | 2020 |
Rise in the prevalence of resistance to extended-spectrum cephalosporins in the USA, nursing homes and antibiotic prescribing in outpatient and inpatient settings.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Enterobacteriaceae Infections; Humans; Inpatients; Nursing Homes; Outpatients; Prevalence | 2021 |
The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Cephamycins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome | 2017 |
Ceftolozane/tazobactam: place in therapy.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Off-Label Use; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Urinary Tract Infections | 2018 |
The ideal patient profile for new beta-lactam/beta-lactamase inhibitors.
Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2018 |
Determining a clinical framework for use of cefepime and β-lactam/β-lactamase inhibitors in the treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Treatment Outcome | 2014 |
Extended-spectrum β-lactamase infections during pregnancy: a growing threat.
Topics: Adult; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications, Infectious; Urinary Tract Infections | 2015 |
Recent Updates on the Role of Pharmacokinetics-pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical Practice.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Staphylococcal Infections; Streptococcus pneumoniae; Vancomycin | 2015 |
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Enterobacteriaceae Infections; Humans; Quinolones; Serratia Infections; Survival Analysis; Treatment Outcome | 2016 |
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2016 |
[Extended-spectrum of beta-lactamases (ESBL): yesterday ESBL: and today ESBL, carbapenemase-producing and multiresistant bacteria].
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; Disinfection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Infant, Newborn | 2012 |
Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literature.
Topics: Cefepime; Cephalosporins; Cerebral Ventricles; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Middle Aged | 2003 |
[Characteristics and clinical value of extended-spectrum beta-lactamases].
Topics: Adolescent; Adult; Aged; Animals; Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Community Health Centers; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella; Middle Aged; Penicillins; Russia | 2003 |
Extended-spectrum beta-lactamases: a clinical update.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Microbial Sensitivity Tests; Plasmids | 2005 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections | 2006 |
Enterobacteriaceae.
Topics: Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans | 2007 |
The spread of CTX-M-type extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Models, Molecular; Prevalence | 2008 |
Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Injections, Intravenous; Microbial Sensitivity Tests; United States | 2008 |
Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2008 |
beta-Lactams without a suicide inhibitor.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Meropenem; Microbial Sensitivity Tests; Penicillins; Thienamycins | 2008 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
The cephalosporin compounds in severe neonatal infection.
Topics: Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Enterobacteriaceae Infections; Humans; Infant, Newborn; Meningitis; Moxalactam; Sepsis | 1984 |
Escherichia vulneris in a Danish soccer wound.
Topics: Adolescent; Cefuroxime; Cephalosporins; Debridement; Denmark; Enterobacteriaceae Infections; Escherichia; Humans; Leg Injuries; Male; Soccer; Wound Infection | 1997 |
[Contribution to the treatment of acute bovine mastitis with cefquinome].
Topics: Animals; Cattle; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Mastitis, Bovine; Multicenter Studies as Topic | 1997 |
[Ceftibuten (Cedax)--a novel third generation oral cephalosporin in the treatment of bacterial infections].
Topics: Administration, Oral; Adult; Ceftibuten; Cephalosporins; Child, Preschool; Enterobacteriaceae Infections; Gram-Positive Bacterial Infections; Humans; Infant; Microbial Sensitivity Tests; Respiratory Tract Infections; Urinary Tract Infections | 1998 |
Important and emerging beta-lactamase-mediated resistances in hospital-based pathogens: the Amp C enzymes.
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Humans | 1998 |
[Citrobacter freundii endocarditis].
Topics: Aged; Aortic Valve; Cefotaxime; Cephalosporins; Citrobacter freundii; Endocarditis, Bacterial; Enterobacteriaceae Infections; Heart Valve Diseases; Humans; Male; Mitral Valve | 1999 |
Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2000 |
Cephalosporins: a microbiological update.
Topics: beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Drug Therapy; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Italy; Microbial Sensitivity Tests; Plasmids | 2000 |
Extended-spectrum beta-lactamases: epidemiology, detection, and treatment.
Topics: beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Microbial Sensitivity Tests; Risk Factors | 2001 |
Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Cephalosporins; Clinical Trials as Topic; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome | 2002 |
[Cephalosporins].
Topics: Cephalosporins; Chemical Phenomena; Chemistry; Drug Hypersensitivity; Enterobacteriaceae Infections; Humans; Kidney Diseases; Staphylococcal Infections; Structure-Activity Relationship | 1977 |
Use of third-generation cephalosporins. Enterobacteriaceae.
Topics: Animals; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 1991 |
Enterobacter: an emerging nosocomial pathogen.
Topics: Bacteriophage Typing; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Sepsis; Serotyping | 1988 |
Cephalosporins.
Topics: Acute Kidney Injury; Anemia, Hemolytic; Cephaloridine; Cephalosporins; Cephalothin; Chemical Phenomena; Chemistry; Drug Eruptions; Drug Hypersensitivity; Enterobacteriaceae Infections; Humans; Infections; Pain; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1970 |
Cephalexin.
Topics: Absorption; Animals; Aqueous Humor; Bacteria; Biological Assay; Cats; Cephalosporins; Chemical Phenomena; Chemistry; Diarrhea; Dogs; Drug Eruptions; Enterobacteriaceae Infections; Haplorhini; Humans; Infections; Kidney; Mice; Pharyngitis; Pneumonia, Pneumococcal; Protein Binding; Pruritus; Rabbits; Rats; Serum Albumin; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1970 |
Antibiotics in pelvic infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Colistin; Drug Hypersensitivity; Enterobacteriaceae Infections; Erythromycin; Female; Gonorrhea; Humans; Kidney Diseases; Mycoplasma Infections; Pelvic Inflammatory Disease; Salpingitis; Staphylococcal Infections; Streptococcal Infections; Streptomycin; Tetracycline; Thrombophlebitis; Tuberculosis, Female Genital; Wound Infection | 1969 |
25 trial(s) available for cephalosporin c and Cronobacter Infections
Article | Year |
---|---|
Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Double-Blind Method; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult | 2016 |
Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Cephalosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterobacteriaceae Infections; Female; Follow-Up Studies; Humans; Injections, Intravenous; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Recurrence; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult | 2016 |
Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Citrobacter freundii; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome | 2009 |
Efficacy of conventional and extended intra-mammary treatment of persistent sub-clinical mastitis with cefquinome in lactating dairy cows.
Topics: Animals; Anti-Bacterial Agents; Asymptomatic Infections; Cattle; Cell Count; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Injections, Intradermal; Iran; Mammary Glands, Animal; Mastitis, Bovine; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Time Factors | 2011 |
Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Klebsiella Infections; Mammary Glands, Animal; Mastitis, Bovine | 2011 |
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data.
Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections | 2003 |
High-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Critical Illness; Cross Infection; Drug Therapy, Combination; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Skilled Nursing Facilities | 2006 |
The prophylaxis of surgical wound infection: is cefuroxime any better than cephaloridine?
Topics: Abdomen; Aged; Cefuroxime; Cephaloridine; Cephalosporins; Clinical Trials as Topic; Double-Blind Method; Enterobacteriaceae Infections; Humans; Middle Aged; Premedication; Prospective Studies; Random Allocation; Staphylococcal Infections; Surgical Wound Infection | 1982 |
Ceftizoxime in the treatment of urinary tract infections.
Topics: Adolescent; Adult; Aged; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas Infections; Random Allocation; Urinary Tract Infections | 1982 |
[Microbiological, kinetic and clinical study on a new cephamycin: cefotetan].
Topics: Adolescent; Adult; Aged; Bronchopneumonia; Cefotetan; Cephalosporins; Cephamycins; Clinical Trials as Topic; Drug Tolerance; Enterobacteriaceae Infections; Female; Half-Life; Humans; Klebsiella Infections; Male; Middle Aged; Respiratory Tract Infections; Urinary Tract Infections | 1983 |
Ceftazidime: aspects of efficacy and tolerance.
Topics: Bacterial Infections; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Coombs Test; Enterobacteriaceae Infections; Eosinophilia; Humans; Liver Function Tests; Neutropenia; Pseudomonas Infections; Staphylococcal Infections | 1983 |
A random comparative trial of 0.25, 0.5 and 1.0 g ceftazidime twice daily in urinary tract infection.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Drug Administration Schedule; Enterobacteriaceae Infections; Female; Humans; Liver Function Tests; Male; Middle Aged; Pseudomonas Infections; Random Allocation; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1983 |
Antimicrobial prophylaxis in acute leukaemia: prospective randomized study comparing two methods of selective decontamination.
Topics: Acute Disease; Adolescent; Adult; Aged; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Candidiasis; Cephalosporins; Enterobacteriaceae Infections; Female; Flucytosine; Humans; Leukemia; Male; Middle Aged; Oxacillin; Penicillins; Prospective Studies; Staphylococcal Infections; Streptococcal Infections | 1983 |
Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward.
Topics: Base Sequence; Ceftazidime; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Child; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Neoplasms; Nucleic Acid Hybridization; Oncology Service, Hospital; Polymerase Chain Reaction | 1995 |
Comparison of antibiotic administration in conjunction with supportive measures versus supportive measures alone for treatment of dairy cows with clinical mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Cephapirin; Combined Modality Therapy; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Mastitis, Bovine; Microbial Sensitivity Tests; Oxytetracycline; Recurrence; Severity of Illness Index; Streptococcal Infections; Treatment Outcome | 1998 |
Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients.
Topics: Adult; Amikacin; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Fever; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neutropenia; Teicoplanin; Vancomycin | 1998 |
Treatment of lower urinary tract infection in pregnancy.
Topics: Adult; Anti-Infective Agents, Urinary; Bacteriuria; Cephalosporins; Enterobacteriaceae Infections; Female; Fosfomycin; Humans; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Risk Factors; Staphylococcal Infections | 2001 |
Comparative study of ceftibuten and cefixime in the treatment of complicated urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Cefixime; Ceftibuten; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2001 |
Cefamandole and cefazolin in the therapy of complicated urinary tract infections.
Topics: Aged; Cefamandole; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Klebsiella Infections; Male; Proteus Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1978 |
Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Intestines; Klebsiella pneumoniae; Middle Aged; Nalidixic Acid; Neomycin; Paris; Random Allocation; Risk Factors | 1989 |
Selective cefuroxime prophylaxis following colorectal surgery based on intra-operative dipslide culture.
Topics: Cefuroxime; Cephalosporins; Colon; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Metronidazole; Prospective Studies; Random Allocation; Rectum; Staphylococcal Infections; Staphylococcus; Surgical Wound Infection | 1986 |
[Results of clinical trials with cephadrine in children].
Topics: Adolescent; Bacterial Infections; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Cyclohexanes; Diarrhea; Drug Evaluation; Enterobacteriaceae Infections; Escherichia coli Infections; Haemophilus Infections; Hematoma; Humans; Infant; Klebsiella Infections; Leukocytosis; Nausea; Osteomyelitis; Otitis; Pharyngitis; Pneumococcal Infections; Pneumonia; Proteus Infections; Pyelonephritis; Pyoderma; Sepsis; Sinusitis; Staphylococcal Infections; Streptococcal Infections; Time Factors; Vomiting | 1973 |
[Cephazolin: bacteriological study and clinical results].
Topics: Bacteria; Bacterial Infections; Cephalosporins; Clinical Trials as Topic; Drug Evaluation; Drug Tolerance; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Statistics as Topic | 1974 |
[Bacteriological, pharmacological and clinical study of cephazolin].
Topics: Adult; Aged; Bacteria; Bacterial Infections; Body Weight; Cephalosporins; Clinical Trials as Topic; Drug Evaluation; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections | 1974 |
417 other study(ies) available for cephalosporin c and Cronobacter Infections
Article | Year |
---|---|
The role of tazobactam-based combinations for the management of infections due to extended-spectrum β-lactamase-producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Combinations; Enterobacteriaceae Infections; Humans; Pharmacists; Piperacillin, Tazobactam Drug Combination; Societies, Medical; Tazobactam; United States | 2021 |
Extended spectrum cephalosporin resistant enterobacteriaceae carriage and infection in patients admitted with newly-diagnosed acute leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Feces; Hospitalization; Humans; Leukemia, Myeloid, Acute; Male; Monobactams | 2023 |
Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) in healthcare and community settings in Botswana: an antibiotic resistance in communities and hospitals (ARCH) study.
Topics: Adult; Anti-Bacterial Agents; Botswana; Carbapenems; Cephalosporins; Child; Communicable Disease Control; COVID-19; Delivery of Health Care; Drug Resistance, Microbial; Enterobacteriaceae Infections; Hospitals; Humans | 2022 |
Risk factors and molecular epidemiology of fecal carriage of carbapenem resistant Enterobacteriaceae in patients with liver disease.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Liver Diseases; Molecular Epidemiology; Multilocus Sequence Typing; Risk Factors | 2023 |
Genomic Modification of TonB and Emergence of Small-Colony Phenotype in VIM- and NDM-Producing Escherichia coli following Cefiderocol Exposure
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefiderocol; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli; Genomics; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Siderophores | 2023 |
Occurrence of and risk factors for extended-spectrum cephalosporin-resistant Enterobacteriaceae determined by sampling of all Norwegian broiler flocks during a six month period.
Topics: Animals; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Chickens; Enterobacteriaceae; Enterobacteriaceae Infections; Norway; Poultry Diseases; Risk Factors | 2019 |
Breakpoint beware: reliance on historical breakpoints for Enterobacteriaceae leads to discrepancies in interpretation of susceptibility testing for carbapenems and cephalosporins and gaps in detection of carbapenem-resistant organisms.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Humans; Pakistan; United States | 2020 |
Selective culture enrichment and sequencing of feces to enhance detection of antimicrobial resistance genes in third-generation cephalosporin resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Cephalosporins; Computational Biology; Culture Techniques; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Humans; Sequence Analysis, DNA | 2019 |
An easy-to-use scoring system for predicting bacteraemia with third-generation cephalosporin-resistant Enterobacterales in a low-resistance setting.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Research Design; Retrospective Studies; Risk Factors | 2020 |
Risk factors for third-generation cephalosporin resistant Enterobacteriaceae in gestational urine cultures: A retrospective cohort study based on centralized electronic health records.
Topics: Adult; Anti-Bacterial Agents; Bacteriuria; Cephalosporin Resistance; Cephalosporins; Electronic Health Records; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gestational Age; Humans; Israel; Pregnancy; Retrospective Studies; Risk Factors; Young Adult | 2020 |
In vitro activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa causing urinary, intra-abdominal and lower respiratory tract infections in intensive care units in Portugal: The STEP multicenter study.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Intensive Care Units; Intraabdominal Infections; Portugal; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Tazobactam; Urinary Tract Infections | 2020 |
Unorthodox Parenteral β-Lactam and β-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactamase Inhibitors; Cephalosporins; China; Drug Combinations; Drug Misuse; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Inappropriate Prescribing; India; Microbial Sensitivity Tests; Patient Care; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam; Tazobactam | 2020 |
Ceftobiprole: a potential empirical post-operative monotherapy in prosthetic joint infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Coinfection; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Prosthesis-Related Infections; Retrospective Studies; Staphylococcal Infections | 2020 |
Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 2020 |
Bacterial Resistance to Cephalosporin Treatment in Elderly Stable Patients Hospitalized With a Urinary Tract Infection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Length of Stay; Male; Retrospective Studies; Treatment Outcome; Urinary Tract Infections | 2020 |
Activity of ceftolozane-tazobactam and comparators when tested against bacterial surveillance isolates collected from patients at risk of infections caused by resistant gram-negative pathogens.
Topics: Aged; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Immunocompromised Host; Inpatients; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
Third-generation cephalosporin resistant Enterobacteriaceae in neonates and young infants: impact and outcome.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Retrospective Studies | 2022 |
[External Validation of Carbapenem-Resistant
Topics: Aged; Anti-Bacterial Agents; APACHE; Carbapenem-Resistant Enterobacteriaceae; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Models, Statistical; Retrospective Studies; Risk Factors; Secondary Care Centers | 2020 |
Resistance to extended-spectrum cephalosporins in Escherichia coli and other Enterobacterales from Canadian turkeys.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Poultry Diseases; Turkeys | 2020 |
Neonatal septicemia caused by a rare pathogen: Raoultella planticola - a report of four cases.
Topics: Anti-Bacterial Agents; Birth Weight; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gestational Age; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Neonatal Sepsis; Piperacillin | 2020 |
Importance of Reviewing Antibiotic Courses by 48 Hours: Risk Factors for Third-Generation Cephalosporin Resistance Among AmpC Harboring Organisms in Urine and Respiratory Cultures.
Topics: Adolescent; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Proteins; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Citrobacter; Cohort Studies; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Infant; Male; Morganella; Retrospective Studies; Risk Factors; Serratia | 2021 |
The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgery.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefuroxime; Cephalosporins; Colorectal Surgery; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Ertapenem; Humans; Metronidazole; Spectroscopy, Fourier Transform Infrared | 2021 |
Risks and burdens of third-generation cephalosporin resistant Enterobacteriaceae in neonatal sepsis.
Topics: Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospital Mortality; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Neonatal Sepsis; Retrospective Studies; Risk Factors; Thailand | 2020 |
Prevalence and antimicrobial resistance of
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Cephalosporins; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Klebsiella; Prevalence; Republic of Korea | 2021 |
Mortality associated with third generation cephalosporin-resistance in Enterobacteriaceae infections: a multicenter cohort study in Southern China.
Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Cross Infection; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged | 2021 |
Comparison of stool samples and rectal swabs with and without pre-enrichment for the detection of third-generation cephalosporin-resistant Enterobacterales (3GCREB).
Topics: Anti-Bacterial Agents; Carrier State; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Humans; Rectum | 2021 |
Epidemiology, risk factors, and prediction score of carbapenem resistance among inpatients colonized or infected with 3rd generation cephalosporin resistant Enterobacterales.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Carbapenem-Resistant Enterobacteriaceae; Case-Control Studies; Cephalosporins; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Incidence; Inpatients; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; ROC Curve | 2021 |
Comparing the therapeutic efficacies of third-generation cephalosporins and broader-spectrum β-lactams as appropriate empirical therapy in adults with community-onset monomicrobial Enterobacteriaceae bacteraemia: a propensity score matched analysis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cephalosporins; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Propensity Score; Treatment Outcome | 2017 |
WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Cyclooctanes; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperidines; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Expansion of highly stable bla
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Host Specificity; Humans; India; Integrons; Male; Microbial Sensitivity Tests; Multigene Family; Species Specificity; Tertiary Care Centers | 2017 |
Ceftaroline Activity Tested Against Bacterial Isolates Causing Community-acquired Respiratory Tract Infections and Skin and Skin Structure Infections in Pediatric Patients From United States Hospitals: 2012-2014.
Topics: Adolescent; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Haemophilus influenzae; Hospitals; Humans; Infant; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections; Retrospective Studies; Skin Diseases, Bacterial; Staphylococcal Infections; Streptococcus pneumoniae; United States | 2017 |
Multicenter Study of Outcomes with Ceftazidime-Avibactam in Patients with Carbapenem-Resistant Enterobacteriaceae Infections.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospital Mortality; Humans; Microbial Sensitivity Tests; Retrospective Studies | 2017 |
In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Greece; Hospitals, University; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tigecycline | 2017 |
Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross-Sectional Studies; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Italy; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Outpatients; Proteus Infections; Proteus mirabilis | 2017 |
A novel transposon, Tn6306, mediates the spread of bla
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; China; DNA Transposable Elements; DNA, Bacterial; Enterobacteriaceae Infections; Hospitals; Humans; Incidence; Microbial Sensitivity Tests; Plasmids; Retrospective Studies; Sequence Analysis, DNA | 2017 |
Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Urinary Tract Infections | 2018 |
The Transmissibility of Antibiotic-Resistant Enterobacteriaceae in Intensive Care Units.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Intensive Care Units; Klebsiella Infections; Longitudinal Studies; Microbial Sensitivity Tests; Models, Theoretical; Prospective Studies | 2018 |
Evaluation of the β-Lacta Test for Detection of Extended-Spectrum-β-Lactamase (ESBL)-Producing Organisms Directly from Positive Blood Cultures by Use of Smudge Plates.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; Blood; Cephalosporin Resistance; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2017 |
Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.
Topics: Aged; Aged, 80 and over; Carbapenems; Cephalosporins; Cohort Studies; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Rectum | 2017 |
Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Retrospective Studies | 2017 |
Antimicrobial Activity of Ceftolozane-Tazobactam Tested Against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2013-2016) as Part of the Surveillance Program: Program to Assess Ceftolozane-Tazoba
Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Thienamycins | 2018 |
High Rates of Human Fecal Carriage of mcr-1-Positive Multidrug-Resistant Enterobacteriaceae Emerge in China in Association With Successful Plasmid Families.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier State; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Proteins; Feces; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Prevalence; Whole Genome Sequencing | 2018 |
Potential of high-dose cefepime/tazobactam against multiresistant Gram-negative pathogens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam | 2018 |
Isolation and characterization of multidrug-resistant Leclercia species from animal clinical case.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Coinfection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Animal; Immunocompromised Host; India | 2018 |
Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Hospitalization; Humans; Isoenzymes; Meropenem; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Plasmids; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Retrospective Studies; Tazobactam; United States | 2018 |
Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Dose-Response Relationship, Drug; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2018 |
Prevalence and mechanisms of extended-spectrum cephalosporin resistance in clinical and fecal Enterobacteriaceae isolates from dogs in Ontario, Canada.
Topics: Animals; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Dog Diseases; Dogs; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae | 2018 |
Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; France; Glycopeptides; Guidelines as Topic; Hospitals; Humans; Intensive Care Units; Logistic Models; Piperacillin, Tazobactam Drug Combination; Practice Patterns, Physicians'; Prescriptions; Probability; Retrospective Studies | 2018 |
Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Illinois; Microbial Sensitivity Tests; Middle Aged; Prevalence; Urinary Tract Infections; Young Adult | 2018 |
A nitrocefin disc supplemented with ertapenem for rapid screening of carbapenemase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2018 |
High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Fluoroquinolones; Germany; Hospitalization; Hospitals, University; Humans; Klebsiella; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Prospective Studies | 2018 |
Detection of qnrVC6, within a new genetic context, in an NDM-1-producing Citrobacter freundii clinical isolate from Uruguay.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Citrobacter freundii; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Middle Aged; Plasmids; Quinolones; Uruguay | 2018 |
Which non-carbapenem antibiotics are active against extended-spectrum β-lactamase-producing Enterobacteriaceae?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam; Urinary Tract Infections | 2018 |
Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant enterobacteria in suspected bacterial infections: a nested case-control study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors | 2018 |
Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017.
Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Centers for Disease Control and Prevention, U.S.; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; United States | 2018 |
Maintenance of Carbapenemase-Producing Enterobacteriaceae in a Farrow-to-Finish Swine Production System.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Farms; Feces; Female; Livestock; Male; Plasmids; Pregnancy; Swine; Swine Diseases | 2018 |
Sequencing of pT5282-CTXM, p13190-KPC and p30860-NR, and comparative genomics analysis of IncX8 plasmids.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Carbapenems; Cephalosporins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Evolution, Molecular; Fluoroquinolones; Gene Expression; Genetic Variation; Genomics; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multigene Family; Penicillins; Phylogeny; Plasmids; Replicon | 2018 |
Plasmid-Mediated AmpC β-Lactamase and Underestimation of Extended-Spectrum β-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Diagnostic Errors; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Japan; Microbial Sensitivity Tests; Phenotype | 2018 |
First report of the isolation of bla
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Japan; Levofloxacin; Microbial Sensitivity Tests | 2018 |
Outcome of children with ESBL-E. coli acute pyelonephritis treated with cephalosporins.
Topics: Cephalosporinase; Cephalosporins; Child; Enterobacteriaceae Infections; Escherichia coli; Humans; Pyelonephritis | 2018 |
Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Colistin; Comoros; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genome, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Young Adult | 2018 |
Antimicrobial activity of ceftolozane-tazobactam tested against Enterobacteriaceae and Pseudomonas aeruginosa collected from patients with bloodstream infections isolated in United States hospitals (2013-2015) as part of the Program to Assess Ceftolozane-
Topics: Anti-Infective Agents; Bacteremia; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Hospitals; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; United States | 2018 |
Clinical characteristics of Citrobacter meningitis in adults: High incidence in patients with a postneurosurgical state and strains not susceptible to third-generation cephalosporins.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Citrobacter; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Humans; Incidence; Male; Meningitis, Bacterial; Middle Aged; Retrospective Studies | 2018 |
Mechanisms of Resistance in Clinical Isolates of
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Electron Transport Complex IV; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Mitochondrial Proteins; Nuclear Proteins | 2018 |
Re: 'Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections' by Rottier, et al.
Topics: Bacteremia; Case-Control Studies; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2018 |
An ancient family of mobile genomic islands introducing cephalosporinase and carbapenemase genes in Enterobacteriaceae.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporinase; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Genome, Bacterial; Genomic Islands; Humans; Infant, Newborn; Klebsiella pneumoniae; Mass Spectrometry; Microbial Sensitivity Tests; Prophages; Sequence Analysis, DNA | 2018 |
Carriage of Extended-spectrum Beta-lactamase-producing Enterobacteriaceae and the Risk of Surgical Site Infection After Colorectal Surgery: A Prospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactamases; Carrier State; Cephalosporins; Colorectal Surgery; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Humans; Israel; Male; Middle Aged; Prospective Studies; Risk Factors; Serbia; Surgical Wound Infection; Switzerland | 2019 |
Molecular characterization of plasmid-encoded Tripoli MBL 1 (TMB-1) in Enterobacteriaceae.
Topics: beta-Lactam Resistance; beta-Lactamases; Bile; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Citrobacter freundii; Conjugation, Genetic; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Gene Transfer, Horizontal; Genes, Bacterial; Humans; Plasmids; Rectum; Whole Genome Sequencing | 2019 |
'Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections' - Author's reply.
Topics: Bacteremia; Case-Control Studies; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans | 2018 |
Drug-resistant Enterobacteriaceae colonization is associated with healthcare utilization and antimicrobial use among inpatients in Pune, India.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; India; Inpatients; Intensive Care Units; Male; Middle Aged; Prospective Studies; Young Adult | 2018 |
Emergence of
Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Chromosome Mapping; Chromosomes, Bacterial; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Genomic Islands; Humans; Integrons; Male; Morganella morganii; Proteus Infections; Providencia; Salmonella typhimurium; Thiamphenicol | 2019 |
Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Pennsylvania; Retrospective Studies; Risk Factors; Urinary Tract Infections | 2018 |
Rapid detection of resistance to carbapenems and cephalosporins in Enterobacteriaceae using liquid chromatography tandem mass spectrometry.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Chromatography, High Pressure Liquid; Enterobacteriaceae Infections; Escherichia coli; Humans; Hydrolysis; Microbial Sensitivity Tests; Tandem Mass Spectrometry; Time Factors | 2018 |
Rapid detection of beta-lactamase production including carbapenemase by thin layer chromatography.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporin Resistance; Cephalosporins; Chromatography, Thin Layer; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2019 |
Incidence of infections due to third generation cephalosporin-resistant
Topics: Aged; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Germany; Hospitals, University; Humans; Incidence; Male; Middle Aged; Patient Admission; Prospective Studies | 2018 |
Nitro-Carba test, a novel and simple chromogenic phenotypic method for rapid screening of carbapenemase-producing Enterobacteriaceae.
Topics: Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Enterobacteriaceae Infections; Humans; Hydrolysis; Microbial Sensitivity Tests; Reproducibility of Results | 2019 |
Prevalence and genetic characterization of cephalosporin-resistant Enterobacteriaceae among dogs and cats in an animal shelter.
Topics: Animals; beta-Lactamases; Cats; Cephalosporins; Dogs; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Infections; Feces; Female; Genotyping Techniques; Japan; Male; Pets; Phylogeny; Prevalence; Rectum | 2019 |
The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Urinary Tract Infections | 2019 |
A novel disk-based detection method with superior sensitivity for β-lactamase production in third-generation cephalosporin-resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2019 |
Carbapenem and Cephalosporin Resistance among Enterobacteriaceae in Healthcare-Associated Infections, California, USA
Topics: beta-Lactam Resistance; California; Carbapenems; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Geography, Medical; Humans; Microbial Sensitivity Tests | 2019 |
Antibiotic-resistant
Topics: Adult; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Feces; Female; Gastrointestinal Microbiome; Humans; India; Male; Middle Aged; Pseudomonas aeruginosa; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Young Adult | 2019 |
Polyclonal gut colonization with extended-spectrum cephalosporin- and/or colistin-resistant Enterobacteriaceae: a normal status for hotel employees on the island of Zanzibar, Tanzania.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriological Techniques; Carrier State; Cephalosporins; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Polymerase Chain Reaction; Prevalence; Rectum; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tanzania; Young Adult | 2019 |
Characteristics of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae Isolates from rivers and lakes in Switzerland.
Topics: Animals; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Humans; Klebsiella pneumoniae; Lakes; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Rivers; Switzerland; Water Microbiology | 2013 |
Faecal carriage of oxyiminocephalosporin-resistant Enterobacteriaceae among paediatric units in different hospitals in the south of France.
Topics: Adolescent; Anti-Bacterial Agents; Carrier State; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; France; Genes, Bacterial; Hospitals; Humans; Infant; Male; Prospective Studies | 2013 |
Detection of ESBL among AmpC producing enterobacteriaceae using inhibitor-based method.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Body Fluids; Boronic Acids; Cefepime; Cefoxitin; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Gene Expression Regulation, Bacterial; Humans; Substrate Specificity | 2013 |
Cross-sectional study on fecal carriage of Enterobacteriaceae with resistance to extended-spectrum cephalosporins in primary care patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross-Sectional Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Humans; Male; Middle Aged; Primary Health Care; Switzerland | 2013 |
Do patient data really support the clinical and laboratory standards institute recommendation for lowering third-generation cephalosporin interpretive breakpoints?
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2013 |
The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Cohort Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitalization; Humans; Meropenem; Microbial Sensitivity Tests; Middle Aged; Propensity Score; Thienamycins | 2013 |
Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Drug Prescriptions; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; United Kingdom | 2013 |
Reply to Altshuler et al.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2013 |
Treatment of extended-spectrum Beta-lactamase enterobacteriaceae with cefepime: the dose matters, too.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male | 2013 |
Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Epidemiological Monitoring; Escherichia coli; Female; Fluoroquinolones; Humans; India; Islands; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Proteus mirabilis; Urinary Tract Infections | 2013 |
Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan:
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Humans; Intensive Care Units; Microbial Sensitivity Tests; Taiwan | 2015 |
Lowering of third generation cephalosporin breakpoints.
Topics: Anti-Bacterial Agents; Bacteria; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2013 |
Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae.
Topics: Belgium; beta-Lactam Resistance; Cephalosporins; Chromogenic Compounds; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; False Negative Reactions; France; Humans; Microbial Sensitivity Tests; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity | 2013 |
Maternal carriage of extended-spectrum beta-lactamase-producing Escherichia coli isolates in Argentina.
Topics: Anti-Bacterial Agents; Argentina; beta-Lactamases; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Gestational Age; Humans; Maternal Exposure; Microbial Sensitivity Tests; Pregnancy; Prevalence; Vagina | 2013 |
Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Empyema; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Levofloxacin; Male; Middle Aged; Treatment Outcome | 2014 |
Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Infection Control | 2013 |
Clinical pharmacodynamics of antipseudomonal cephalosporins in patients with ventilator-associated pneumonia.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Retrospective Studies | 2014 |
Characterization of KPC-2-producing Escherichia coli, Citrobacter freundii, Enterobacter cloacae, Enterobacter aerogenes, and Klebsiella oxytoca isolates from a Chinese Hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; China; Cross Infection; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Hospitals; Humans; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Survival Analysis | 2014 |
Rapid detection of β-lactamase-hydrolyzing extended-spectrum cephalosporins in Enterobacteriaceae by use of the new chromogenic βLacta test.
Topics: Bacterial Proteins; beta-Lactamases; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Hydrolysis; Microbial Sensitivity Tests | 2014 |
Activity of ceftaroline-avibactam tested against contemporary Enterobacteriaceae isolates carrying β-lactamases prevalent in the United States.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftaroline; Cephalosporins; Drug Combinations; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Prevalence; Proteus mirabilis; United States | 2014 |
Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefepime; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Survival Analysis; Treatment Outcome | 2014 |
Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan.
Topics: Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; beta-Lactamases; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Imipenem; Infection Control; Inosine Monophosphate; Japan; Male; Meropenem; Middle Aged; Phylogeny; R Factors; Retrospective Studies; Risk Factors; Tertiary Healthcare; Thienamycins | 2014 |
Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Catchment Area, Health; Cephalosporins; Cohort Studies; Comorbidity; Cross Infection; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; France; Hospitalization; Hospitals, Teaching; Hospitals, Urban; Humans; Institutionalization; Long-Term Care; Middle Aged; Nalidixic Acid; Ofloxacin; Pyelonephritis; Retrospective Studies; Risk Factors | 2014 |
Pediatric infection and intestinal carriage due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; Carrier State; Cephalosporins; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Genotype; Humans; Infant; Intestines; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Risk Factors | 2014 |
Assessment of five screening strategies for optimal detection of carriers of third-generation cephalosporin-resistant Enterobacteriaceae in intensive care units using daily sampling.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; Carrier State; Cephalosporins; Critical Care; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infection Control; Intensive Care Units; Male; Mass Screening; Microbial Sensitivity Tests; Middle Aged; Rectum; Retrospective Studies; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
pRMH760, a precursor of A/C₂ plasmids carrying blaCMY and blaNDM genes.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cephalosporins; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Gene Expression Regulation, Bacterial; Genotype; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Insertional; Phenotype; Plasmids | 2014 |
New broad-spectrum β-lactamases emerging among Enterobacteriaceae from healthy cats and dogs: a public health concern?
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carrier State; Cats; Cephalosporins; Dogs; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Mutation; Plasmids; Public Health | 2014 |
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12).
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Genotype; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2014 |
Clinical manifestations and prognostic factors of Morganella morganii bacteremia.
Topics: Age Factors; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Morganella morganii; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Taiwan | 2015 |
Detection of PEr 1 extended-spectrum β-lactamase among nosocomial providencia stuartii isolates in Tunisia.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Hospitals, Military; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Providencia; Tunisia | 2014 |
Amikacin prophylaxis and risk factors for surgical site infection after kidney transplantation.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antilymphocyte Serum; beta-Lactamases; Cephalosporins; Child; Cohort Studies; Delayed Graft Function; Enterobacteriaceae Infections; Female; Graft Survival; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Renal Insufficiency; Risk Factors; Surgical Wound Infection; Time Factors; Tissue Donors; Treatment Outcome; Young Adult | 2015 |
Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Case-Control Studies; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2014 |
Supporting the ceftaroline fosamil/avibactam Enterobacteriaceae breakpoint determination using humanised in vivo exposures in a thigh model.
Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Ceftaroline; Cephalosporins; Disease Models, Animal; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Reproducibility of Results; Thigh | 2014 |
Evaluation of the efficiency of cefoxitin/cefepime combination against Enterobacteriaceae resistant to expanded-spectrum cephalosporins.
Topics: Animal Structures; Animals; Bacterial Load; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cefoxitin; Cephalosporins; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Mice; Microbial Sensitivity Tests; Survival Analysis; Treatment Outcome | 2015 |
Secular trends associated with Enterobacteriaceae with a cefepime susceptible-dose-dependent MIC.
Topics: Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2015 |
Drug resistance and molecular epidemiology of aerobic bacteria isolated from puerperal infections in Bangladesh.
Topics: Adult; Anti-Bacterial Agents; Bangladesh; Base Sequence; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Multilocus Sequence Typing; Phylogeny; Plasmids; Puerperal Infection; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus haemolyticus | 2015 |
In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; China; Enterobacteriaceae Infections; Escherichia coli; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Proteus mirabilis; Sequence Analysis, DNA | 2015 |
Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiologic Methods; Female; Guideline Adherence; Humans; Male; Middle Aged; Netherlands; Predictive Value of Tests; Retrospective Studies; Sepsis; Young Adult | 2015 |
In vivo activities of simulated human doses of cefepime and cefepime-AAI101 against multidrug-resistant Gram-negative Enterobacteriaceae.
Topics: Animals; beta-Lactamase Inhibitors; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Mice; Microbial Sensitivity Tests | 2015 |
Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cambodia; Cefotaxime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multiplex Polymerase Chain Reaction; Prevalence; Prospective Studies; Sequence Analysis, DNA; Young Adult | 2015 |
Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by Halogens.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catalytic Domain; Ceftazidime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Iodides; Klebsiella Infections; Klebsiella pneumoniae; Molecular Docking Simulation; Protein Conformation | 2015 |
In Vitro Activity of Ceftolozane Alone and in Combination with Tazobactam against Extended-Spectrum-β-Lactamase-Harboring Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Tazobactam | 2015 |
Development of a novel chromogenic method, Penta-well test, for rapid prediction of β-lactamase classes produced in clinical Enterobacteriaceae isolates.
Topics: Bacteriological Techniques; beta-Lactamases; Cephalosporins; Chromogenic Compounds; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hydrolysis; Sensitivity and Specificity; Time Factors | 2015 |
Reduced Susceptibility to Cefepime in Clinical Isolates of Enterobacteriaceae Producing OXA-1 Beta-Lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Humans; Isoenzymes; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Plasmids; Sequence Analysis, DNA; Spain | 2016 |
In vitro activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa and Enterobacteriaceae recovered in Spanish medical centres: Results of the CENIT study.
Topics: Academic Medical Centers; Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Spain; Tazobactam | 2015 |
Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2015 |
Efficacy of humanized high-dose meropenem, cefepime, and levofloxacin against Enterobacteriaceae isolates producing Verona integron-encoded metallo-β-lactamase (VIM) in a murine thigh infection model.
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Levofloxacin; Meropenem; Mice; Microbial Sensitivity Tests; Thienamycins; Thigh | 2015 |
In vitro activities and detection performances of cefmetazole and flomoxef for extended-spectrum β-lactamase and plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefmetazole; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Japan; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2016 |
Population Pharmacokinetic Assessment and Pharmacodynamic Implications of Pediatric Cefepime Dosing for Susceptible-Dose-Dependent Organisms.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Computer Simulation; Creatinine; Drug Dosage Calculations; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Models, Statistical; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Differences in the pharmacodynamics of ceftaroline against different species of Enterobacteriaceae studied in an in vitro pharmacokinetic model of infection.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Models, Theoretical | 2016 |
[THE APPLICATION OF SELECTIVE CHROMOGENIC AGAR FOR DETECTING ENTEROBACTERIA WITH PRODUCTION OF BETA-LACTAMASES].
Topics: Agar; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Cefotetan; Cephalosporins; Chromogenic Compounds; Cloxacillin; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2015 |
Impact of Cefepime Susceptible-Dose-Dependent MIC for Enterobacteriaceae on Reporting and Prescribing.
Topics: Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Prescriptions; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 2016 |
What does the susceptible-dose dependent interpretive category for cefepime in ESBL-producing bacteria?
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Humans; Inactivation, Metabolic; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Practice Guidelines as Topic | 2017 |
Travelers Can Import Colistin-Resistant Enterobacteriaceae, Including Those Possessing the Plasmid-Mediated mcr-1 Gene.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Colistin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; India; Plasmids | 2016 |
Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors.
Topics: Adult; Aged; Anti-Bacterial Agents; Carrier State; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Germany; Hospitalization; Humans; Long-Term Care; Male; Middle Aged; Patient Admission; Prevalence; Prospective Studies; Rectum; Risk Factors | 2016 |
Providencia stuartii Isolates from Greece: Co-Carriage of Cephalosporin (blaSHV-5, blaVEB-1), Carbapenem (blaVIM-1), and Aminoglycoside (rmtB) Resistance Determinants by a Multidrug-Resistant Outbreak Clone.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Clone Cells; Conjugation, Genetic; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Gene Expression; Gene Transfer, Horizontal; Greece; Humans; Male; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Plasmids; Providencia; Quinolones; Replicon; Survival Analysis | 2016 |
Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carrier State; Case-Control Studies; Cephalosporins; Cross Infection; Enterobacteriaceae Infections; Feces; Female; Humans; Israel; Logistic Models; Male; Middle Aged; Respiration, Artificial; Risk Factors; Tertiary Care Centers | 2016 |
What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Intraabdominal Infections; Penicillanic Acid; Pseudomonas Infections; Tazobactam; Urinary Tract Infections | 2016 |
Cephalothin is not a reliable surrogate marker for oral cephalosporins in susceptibility testing of Enterobacteriaceae causing urinary tract infection.
Topics: Anti-Bacterial Agents; Biomarkers; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 2016 |
Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections Due to Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae.
Topics: Academic Medical Centers; Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Drug Resistance, Bacterial; Emergency Service, Hospital; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Facultatively Anaerobic Rods; Humans; Logistic Models; Male; Middle Aged; Pennsylvania; Polymerase Chain Reaction; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2016 |
High third-generation cephalosporin resistant Enterobacteriaceae prevalence rate among neonatal infections in Dakar, Senegal.
Topics: beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Senegal; Tertiary Care Centers; Treatment Outcome | 2016 |
Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cephalosporins; Diagnostic Tests, Routine; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Penicillins | 2017 |
Performance of a novel fluorogenic chimeric analog for the detection of third-generation cephalosporin resistant bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluorescent Dyes; Microbial Sensitivity Tests; Phenolsulfonphthalein; Plasmids; Sensitivity and Specificity | 2016 |
Susceptibility to cephalosporin combinations and aztreonam/avibactam among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; Cephalosporin Resistance; Cephalosporins; Clavulanic Acid; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Germany; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Tazobactam; Young Adult | 2017 |
The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against β-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Computer Simulation; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Cephalosporins; Colistin; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Hospitalization; Humans; Klebsiella; Microbial Sensitivity Tests; Minocycline; Tertiary Care Centers; Tetracycline; Tigecycline | 2017 |
In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Cefepime; Cephalosporins; Citrobacter; Cyclooctanes; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Gram-Negative Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Piperidines | 2017 |
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).
Topics: Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Europe; Humans; Intraabdominal Infections; Israel; Microbial Sensitivity Tests; Penicillanic Acid; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Turkey; Urinary Tract Infections | 2017 |
Intestinal colonisation with extended-spectrum cephalosporin- and colistin-resistant Enterobacteriaceae in HIV-positive individuals in Switzerland: molecular features and risk factors.
Topics: Anti-Bacterial Agents; beta-Lactamases; CD4 Lymphocyte Count; Cephalosporins; Cohort Studies; Colistin; Drug Resistance, Multiple, Bacterial; Dysbiosis; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Feces; HIV Infections; Humans; Intestines; Microbial Sensitivity Tests; Microbiota; Plasmids; Risk Factors; Switzerland | 2017 |
Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cefpirome; Cephalosporin Resistance; Cephalosporins; Chromosomes, Bacterial; Citrobacter freundii; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny | 2008 |
Development of breakpoints of cephems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in the peritoneal fluid of patients.
Topics: Abdomen; Anti-Bacterial Agents; Ascitic Fluid; Cefepime; Cefotiam; Cefozopran; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Laparotomy; Microbial Sensitivity Tests; Monte Carlo Method; Postoperative Complications; Surgical Wound Infection | 2008 |
Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Enterobacter cloacae from a Teaching Hospital in China.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; China; Conjugation, Genetic; Enterobacter cloacae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
In vivo pharmacodynamics of ceftobiprole against multiple bacterial pathogens in murine thigh and lung infection models.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cephalosporin Resistance; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Enterobacteriaceae Infections; Extremities; Female; Gram-Negative Bacterial Infections; Lung Diseases; Methicillin Resistance; Mice; Mice, Inbred ICR; Neutropenia; Penicillin Resistance; Pneumococcal Infections; Staphylococcal Infections; Staphylococcus aureus | 2008 |
High resistance to fourth-generation cephalosporins among clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases isolated in Portugal.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Portugal | 2009 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cambodia; Cephalosporins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Female; Humans; Male; Mali; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Plasmids; Quinolones; Young Adult | 2009 |
[Utility of chromID ESBL medium for detection of cephalosporin-resistant enterobacteria in inoculated blood culture bottles].
Topics: Agar; Bacteremia; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Blood; Cephalosporin Resistance; Cephalosporins; Chromogenic Compounds; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; R Factors; Sensitivity and Specificity | 2009 |
Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Diagnostic Errors; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Humans; Klebsiella; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA | 2009 |
Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Enterobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity | 2010 |
Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Phenotype; Prevalence; Taiwan | 2009 |
Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; Cephalosporin Resistance; Cephalosporins; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Hospitals, Veterans; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Risk Factors; Severity of Illness Index; Taiwan; Treatment Outcome; Young Adult | 2009 |
Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus mirabilis; Sensitivity and Specificity | 2009 |
Efficacy of cefepime therapy for Enterobacter bacteraemia, with special emphasis on febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; Cefepime; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Female; Fever; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Treatment Outcome | 2010 |
Emergence of extended-spectrum beta-lactamase and fluoroquinolone resistance genes among Irish multidrug-resistant isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Genotype; Humans; Ireland; Microbial Sensitivity Tests; Prevalence | 2010 |
Comparative in vitro activity of cefditoren and other antimicrobials against Enterobacteriaceae causing community-acquired uncomplicated urinary tract infections in women: a Spanish nationwide multicenter study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Automation; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; Microbial Sensitivity Tests; Middle Aged; Spain; Urinary Tract Infections; Young Adult | 2010 |
[Multiple brain abscesses complicating Enterobacter cloacae sepsis in a premature infant].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Premature; Treatment Outcome | 2010 |
High level cephalosporin-resistant Enterobacteriaceae ventilator-associated pneumonia: prognostic factors based on a cohort study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Cohort Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prognosis; Retrospective Studies; Severity of Illness Index; Shock | 2011 |
Oral antibiotics for infections due to multidrug-resistant Gram-negative organisms.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefdinir; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Rifampin; Wound Infection | 2011 |
In vivo efficacy of a human-simulated regimen of ceftaroline combined with NXL104 against extended-spectrum-beta-lactamase (ESBL)-producing and non-ESBL-producing Enterobacteriaceae.
Topics: Animals; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Thigh | 2011 |
Wide dissemination of multidrug-resistant Shigella isolates in China.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; beta-Lactamases; Cephalosporins; China; Ciprofloxacin; Clavulanic Acids; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Mutation; Quinolones; Sequence Analysis, DNA; Serotyping; Shigella flexneri | 2011 |
Comparison of plasmid-mediated quinolone resistance and extended-spectrum β-lactamases in third-generation cephalosporin-resistant Enterobacteriaceae from four Irish hospitals.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Ireland; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Prevalence; Quinolones; Sequence Analysis, DNA | 2012 |
Impact of adopting minimum inhibitory concentration as the determinant of susceptibility to cephalosporins and carbapenems in multi-drug resistant Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Research Design | 2012 |
Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Hospitals; Humans; Infant; Male; Middle Aged; Morbidity; Prevalence; Spain; Young Adult | 2011 |
Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporinase; Cephalosporins; DNA, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Hydrolysis; Microbial Sensitivity Tests; Molecular Sequence Data; Selection, Genetic; Sequence Analysis, DNA | 2012 |
Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases.
Topics: Anti-Bacterial Agents; Area Under Curve; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Cephalosporins; Chromatography, Liquid; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance, Bacterial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Biological; Tandem Mass Spectrometry | 2012 |
Detection of extended-spectrum β-lactamase in Enterobacter spp.--evaluation of six phenotypic tests.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Humans; Plasmids; ROC Curve; Sensitivity and Specificity; Sequence Analysis, DNA | 2012 |
Colonisation and infection due to Enterobacteriaceae producing plasmid-mediated AmpC β-lactamases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Cohort Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Infant; Infant, Newborn; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Proteus mirabilis; Spain; Young Adult | 2012 |
Evolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Burn Units; Cephalosporins; Child; Disease Outbreaks; DNA Restriction Enzymes; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Gene Transfer, Horizontal; Gentamicins; Humans; Integrons; Male; Middle Aged; Mutagenesis, Insertional; Plasmids; Providencia; Sequence Deletion; Tunisia | 2012 |
Description and plasmid characterization of qnrD determinants in Proteus mirabilis and Morganella morganii.
Topics: Anti-Bacterial Agents; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Fluoroquinolones; Genes, Bacterial; Humans; Italy; Molecular Sequence Data; Morganella morganii; Plasmids; Proteus mirabilis; Sequence Analysis, DNA | 2012 |
Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.
Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Cloning, Molecular; Enterobacteriaceae Infections; Escherichia coli; Humans; Hydrolysis; Kinetics; Male; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis, Site-Directed; Peritonitis; Postoperative Complications; Protein Structure, Tertiary | 2012 |
Efficacy of human simulated exposures of ceftaroline against phenotypically diverse Enterobacteriaceae isolates.
Topics: Animals; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Immunocompetence; Injections, Intravenous; Klebsiella; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Phenotype; Thigh | 2012 |
[Frequency of enzymes associated with reduced sensitivity to beta-lactam antibiotics in enterobacteria isolates, Caracas, Venezuela].
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Genotype; Hospitals, Urban; Humans; Microbial Sensitivity Tests; Phenotype; Substrate Specificity; Venezuela | 2011 |
Prevalence and predictors of MRSA, ESBL, and VRE colonization in the ambulatory IBD population.
Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; beta-Lactamases; Carrier State; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Female; Histamine H2 Antagonists; Hospitalization; Humans; Inflammatory Bowel Diseases; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Middle Aged; Nose; Prevalence; Proton Pump Inhibitors; Rectum; Risk Factors; Staphylococcal Infections; Vancomycin; Vancomycin Resistance; Young Adult | 2012 |
Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Hospitals; Humans; Male; Middle Aged; Multivariate Analysis; New Zealand; Retrospective Studies; Risk Factors | 2012 |
Proportion of extended-spectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon.
Topics: Adult; beta-Lactam Resistance; beta-Lactamases; Cameroon; Carrier State; Cephalosporins; Community-Acquired Infections; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Human Experimentation; Humans; Male; Microbial Sensitivity Tests; Outpatients; Polymerase Chain Reaction; Risk Factors; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2012 |
Clinical significance of infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC β-lactamase.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Female; Humans; Immunosuppressive Agents; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Survival Rate; Young Adult | 2012 |
Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Humans; Intensive Care Units; Male; Middle Aged; Paris; Prevalence | 2012 |
Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units.
Topics: Anti-Bacterial Agents; Antisepsis; beta-Lactam Resistance; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Gastrointestinal Tract; Humans; Intensive Care Units; Rectum | 2012 |
Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cephalosporins; Cohort Studies; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Treatment Failure | 2012 |
Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010
Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Prevalence; Prospective Studies | 2012 |
Rapid detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactamases; Cephalosporins; Color; Costs and Cost Analysis; Culture Media; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hydrogen-Ion Concentration; Hydrolysis; Sensitivity and Specificity; Time Factors | 2012 |
Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Child; Child, Preschool; Cross Infection; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Genotype; Hospitals; Humans; Infant; Klebsiella pneumoniae; Male; Middle Aged; Molecular Epidemiology; Retrospective Studies; Risk Factors; Serratia marcescens; Tertiary Healthcare; Young Adult | 2012 |
Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Cameroon; Carrier State; Cephalosporins; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Hospitalization; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA | 2013 |
Spread of CTX-M-15 positive Providencia spp. causing urinary tract infections at the University Hospital Split in Croatia.
Topics: beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Providencia; R Factors; Urinary Tract Infections | 2012 |
Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2012 |
Cefditoren: Comparative efficacy with other antimicrobials and risk factors for resistance in clinical isolates causing UTIs in outpatients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Greece; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Outpatients; Pregnancy; Risk Factors; Treatment Outcome; Urinary Tract Infections; Young Adult | 2012 |
Infective endocarditis due to Enterobacter cloacae resistant to third- and fourth-generation cephalosporins.
Topics: Aged; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Cephalosporins; Endocarditis; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Male; Meropenem; Thienamycins; Treatment Outcome | 2015 |
Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome | 2013 |
Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Genotype; Hospitals, University; Humans; Infections; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Survival Analysis; Switzerland; Tertiary Care Centers; Treatment Outcome | 2013 |
Susceptibility patterns to extended-spectrum cephalosporins among Enterobacteriaceae harbouring extended-spectrum β-lactamases using the updated Clinical and Laboratory Standards Institute interpretive criteria.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Greece; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2013 |
Citrobacter koseri pneumonia and meningitis in an infant.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Citrobacter koseri; Enterobacteriaceae Infections; Gentamicins; Humans; Infant, Newborn; Lung Abscess; Male; Meningitis, Bacterial; Pneumonia, Bacterial | 2002 |
Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with enterobacter bacteremia.
Topics: Adult; Aged; Bacteremia; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors | 2002 |
Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method.
Topics: Algorithms; beta-Lactamases; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Isoelectric Focusing; Italy; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Reagent Kits, Diagnostic | 2003 |
Determination of the frequency of inadequate antibiotic therapy using calculation of indication failure (IF), cumulative indication failure (CIF), and balanced indication failure (BIF).
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefepime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Empiricism; Enterobacteriaceae Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Treatment Failure | 2003 |
Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.
Topics: Case-Control Studies; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Cerebrovascular Disorders; Citrobacter freundii; Critical Care; Cross Infection; Enterobacteriaceae Infections; Female; Humans; Length of Stay; Male; Middle Aged; Risk Factors | 2003 |
Resistance to extended-spectrum cephalosporins and mortality in patients with Citrobacter freundii bacteremia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Citrobacter freundii; Confidence Intervals; Enterobacteriaceae Infections; Female; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Probability; Retrospective Studies; Risk Assessment; Survival Analysis; Treatment Outcome | 2003 |
SHV-34: an extended-spectrum beta-lactamase encoded by an epidemic plasmid.
Topics: Amino Acid Substitution; beta-Lactamases; Cephalosporins; Child; Citrobacter koseri; Conjugation, Genetic; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Proteins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Treatment Failure | 2003 |
Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.
Topics: Asia; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Pacific Islands; Penicillins; Phenotype; South Africa | 2003 |
[Morganella morganii and early-onset neonatal infection].
Topics: Administration, Oral; Adult; Aminoglycosides; Amoxicillin; Antibiotic Prophylaxis; Cephalosporins; Chorioamnionitis; Enterobacteriaceae Infections; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infant, Newborn, Diseases; Morganella morganii; Penicillins; Pregnancy; Sepsis | 2004 |
Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae?
Topics: Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Humans | 2004 |
Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate.
Topics: Amino Acid Sequence; Amino Acid Substitution; Cefepime; Cephalosporinase; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Enterobacter aerogenes; Enterobacteriaceae Infections; Genes, Bacterial; Kinetics; Molecular Sequence Data | 2004 |
Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Colony Count, Microbial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Enzyme Inhibitors; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Moxifloxacin; Penicillanic Acid; Penicillins; Piperacillin; Quinolines; Tazobactam | 2004 |
Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Electrophoresis, Gel, Pulsed-Field; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Hospitals, University; Humans; Infant; Infant, Newborn; Intensive Care Units; Middle Aged; Prevalence; Prospective Studies | 2004 |
Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae.
Topics: Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Data Interpretation, Statistical; Drug Utilization; Enterobacter cloacae; Enterobacteriaceae Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Spain | 2004 |
Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella oxytoca; Phenotype | 2004 |
Nursing home residents and Enterobacteriaceae resistant to third-generation cephalosporins.
Topics: Aged; Anti-Bacterial Agents; Canada; Case-Control Studies; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Logistic Models; Microbial Sensitivity Tests; Multivariate Analysis; Nursing Homes; Risk Factors; United States | 2004 |
Evolution of acquired resistance to third-generation cephalosporins in Enterobacteriaceae in a Tunisian hospital 1993-2001.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Disease Outbreaks; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Hospitalization; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus mirabilis; Tunisia | 2004 |
High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns.
Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Cross Infection; Enterobacter; Enterobacteriaceae Infections; Enzyme Inhibitors; Gene Frequency; Genes, Bacterial; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Mutation | 2004 |
A small outbreak of third generation cephem-resistant Citrobacter freundii infection on a surgical ward.
Topics: Aged; Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae Infections; Female; General Surgery; Hospital Units; Hospitals, University; Humans; Male; Middle Aged | 2004 |
PER-1 production in a urinary isolate of Providencia rettgeri.
Topics: Base Sequence; beta-Lactamases; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Incidence; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Providencia; Turkey; Urinalysis; Urine | 2004 |
[Profile of antimicrobial resistance of agents causing urinary tract infections in children].
Topics: Adolescent; Age Factors; Aminoglycosides; Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Cephalosporin Resistance; Cephalosporins; Cephalothin; Child; Child, Preschool; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Infant; Klebsiella pneumoniae; Male; Penicillin Resistance; Proteus mirabilis; Retrospective Studies; Sex Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2004 |
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2004 |
Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacteremia; Case-Control Studies; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae Infections; Female; Hospitals, University; Humans; Korea; Male; Middle Aged; Risk Factors | 2005 |
Unnoticed spread of integron-carrying Enterobacteriaceae in intensive care units.
Topics: Adult; Aged; Anti-Bacterial Agents; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gene Transfer, Horizontal; Humans; Integrases; Integrons; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prevalence; Sequence Analysis, DNA | 2005 |
Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Immunodiffusion; Microbial Sensitivity Tests; Regression Analysis | 2005 |
[Comparison of three microbiological methods for detection of expanded-spectrum betalactamases in Enterobacteriaceae isolated in Santa Fe (Argentina)].
Topics: Argentina; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hydrolysis; Isoelectric Focusing; Microbial Sensitivity Tests; Monobactams; Polymerase Chain Reaction; Sensitivity and Specificity; Substrate Specificity | 2005 |
Emergence of cefotaxime resistance in Citrobacter freundii causing necrotizing fasciitis and osteomyelitis.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Enterobacteriaceae Infections; Ertapenem; Fasciitis, Necrotizing; Female; Humans; Middle Aged; Osteomyelitis; Wounds and Injuries | 2006 |
Prevalence of extended-spectrum beta-lactamases in isolates of the Enterobacter cloacae complex from German hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Genes, Bacterial; Genotype; Germany; Hospitals; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA; Sulfonamides | 2006 |
Comparison of double disc and three dimensional methods to screen for ESBL producers in a tertiary care hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; India; Microbial Sensitivity Tests | 2006 |
Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospital Mortality; Hospitals, University; Humans; Israel; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors | 2006 |
Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; England; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Infant; London; Male; Microbial Sensitivity Tests; Middle Aged | 2006 |
Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae.
Topics: beta-Lactam Resistance; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluoroquinolones; Humans; Urinary Tract Infections | 2006 |
Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; False Positive Reactions; Humans; Microbial Sensitivity Tests; Predictive Value of Tests; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors | 2006 |
Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospita
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli; Greece; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Prospective Studies; Tazobactam; Time Factors | 2007 |
Characterisation of KLUA-9, a beta-lactamase from extended-spectrum cephalosporin-susceptible Kluyvera ascorbata, and genetic organisation of bla(KLUA-9).
Topics: Base Sequence; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Evolution, Molecular; Genes, Bacterial; Humans; In Vitro Techniques; Kinetics; Kluyvera; Molecular Sequence Data; Plasmids | 2007 |
Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
Topics: Aged; Bacteremia; Cephalosporins; Citrobacter freundii; Cohort Studies; Drug Resistance; Enterobacter; Enterobacteriaceae Infections; Female; Hospital Mortality; Humans; Male; Middle Aged; Predictive Value of Tests; Respiration, Artificial; Retrospective Studies; Statistics as Topic; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Extended double disc synergy testing reveals a low prevalence of extended-spectrum beta-lactamases in Enterobacter spp. in Vienna, Austria.
Topics: Anti-Bacterial Agents; Austria; Bacterial Proteins; beta-Lactamases; Cephalosporins; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae Infections; Hospitals, University; Humans; Random Amplified Polymorphic DNA Technique | 2007 |
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Bacteroides; beta-Lactamases; Ceftaroline; Cephalosporins; Clavulanic Acid; Conjugation, Genetic; Drug Combinations; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Escherichia coli; Gram-Negative Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Phenotype; Respiratory Tract Diseases; Staphylococcus | 2007 |
An algorithm to estimate the importance of bacterial acquisition routes in hospital settings.
Topics: Algorithms; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Humans; Intensive Care Units; Likelihood Functions; Markov Chains; Netherlands; Sentinel Surveillance | 2007 |
Characterization of CTX-M-22 and TEM-141 Encoded by a single plasmid from a clinical isolate of Enterobacter cloacae in China.
Topics: Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; China; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids | 2007 |
High rates of antimicrobial co-resistance among Enterobacteriaceae: comparative analysis between clinical isolates resistant and susceptible to third-generation cephalosporins.
Topics: Anti-Bacterial Agents; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Spain | 2007 |
Living with ESBLs. Introduction.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Microbial Sensitivity Tests; Mutation | 2008 |
[Resistance to third generation cephalosporins in Sfax hospitals, Tunisia (1999-2005)].
Topics: Cephalosporins; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies; Suppuration; Tunisia | 2008 |
Research and clinical value of antibacterial-application software.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Imipenem; Isosorbide Dinitrate; Male; Ofloxacin; Software | 2008 |
[ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged; Risk Factors; Urinary Tract Infections | 2007 |
Acute coliform mastitis in buffaloes (Bubalus bubalis): clinical findings and treatment outcomes.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Buffaloes; Cephalosporins; Drug Administration Routes; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Infusions, Parenteral; Mastitis; Treatment Failure; Treatment Outcome | 2008 |
Gram-negative bacillary meningitis. New therapy and changing concepts.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Chloramphenicol; Enterobacteriaceae Infections; Humans; Meningitis; Moxalactam; Pseudomonas Infections | 1982 |
Moxalactam concentration in human aqueous humor after intravenous administration.
Topics: Adult; Aqueous Humor; Cataract Extraction; Cephalosporins; Cephamycins; Endophthalmitis; Enterobacteriaceae Infections; Female; Humans; Injections, Intravenous; Male; Middle Aged; Moxalactam; Postoperative Complications | 1982 |
Successful treatment of gram-negative bacillary meningitis with moxalactam.
Topics: Amikacin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Male; Meningitis; Middle Aged; Moxalactam | 1982 |
Moxalactam in the treatment of pediatric infections.
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Moxalactam | 1982 |
Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli.
Topics: Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Female; Humans; Meningitis; Middle Aged; Moxalactam; Serratia marcescens | 1981 |
Effectiveness of cefoperazone in treating cutaneous infections.
Topics: Alcohol Deterrents; Cefoperazone; Cellulitis; Cephalosporins; Child; Enterobacteriaceae Infections; Foot Dermatoses; Humans; Injections, Intramuscular; Pseudomonas; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections | 1982 |
Gram-negative bacterial toe web infection: successful treatment with a new third generation cephalosporin.
Topics: Adult; Aged; Bacterial Infections; Cefoperazone; Cephalosporins; Enterobacteriaceae Infections; Foot Dermatoses; Humans; Male; Middle Aged; Proteus Infections; Pseudomonas Infections; Skin Diseases, Infectious; Streptococcal Infections; Toes | 1983 |
[Treatment of enterobacterial meningitis in adults with intravenous lamoxactam].
Topics: Adult; Aged; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Female; Humans; Injections, Intravenous; Male; Meningitis; Middle Aged; Moxalactam | 1983 |
Antibiotic penetration in abdominal infection: a case of tobramycin failure responsive to moxalactam.
Topics: Abdomen; Anti-Bacterial Agents; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae Infections; Humans; Male; Middle Aged; Moxalactam; Postoperative Complications; Tobramycin | 1983 |
[Cefotaxime CSF levels in children with purulent meningitis (author's transl)].
Topics: Cefotaxime; Cephalosporins; Child; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Meningitis; Meningitis, Haemophilus | 1981 |
[Place of cefotaxime in the treatment of septicaemias due to enterobacteriaceae (author's transl)].
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Sepsis | 1981 |
[Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Meningitis; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1981 |
[Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)].
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Child; Enterobacteriaceae Infections; Humans; Middle Aged; Sepsis | 1981 |
[Cefotaxime treatment of 25 cases of severe enterobacteriaceae infections in an intensive care unit (author's transl)].
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Critical Care; Enterobacteriaceae Infections; Humans; Infusions, Parenteral; Middle Aged | 1981 |
[Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)].
Topics: Acinetobacter Infections; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Pneumonia; Urinary Tract Infections | 1981 |
[Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Child; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1981 |
[Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
Topics: Cefotaxime; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Meningitis, Haemophilus; Pseudomonas Infections; Salmonella Infections | 1981 |
[Cefotaxime and Gram-negative infections in children. Effectiveness and tolerance (author's transl)].
Topics: Adolescent; Cefotaxime; Cephalosporins; Child; Child, Preschool; Enterobacteriaceae Infections; Fusobacterium Infections; Haemophilus Infections; Humans; Infant; Infant, Newborn; Injections, Intramuscular; Injections, Intravenous | 1981 |
[Cefotaxime in digestive tract infections (author's transl)].
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Digestive System Diseases; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Staphylococcal Infections | 1981 |
[Cefotaxime in bronchopulmonary infections (author's transl)].
Topics: Adolescent; Adult; Aged; Bronchitis; Cefotaxime; Cephalosporins; Enterobacteriaceae Infections; Female; Haemophilus Infections; Humans; Male; Middle Aged; Pneumonia; Staphylococcal Infections; Streptococcal Infections | 1981 |
Serratia endocarditis in a pediatric burn patient. Cure with cefotaxime.
Topics: Burns; Cefotaxime; Cephalosporins; Child; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Humans; Sepsis; Serratia marcescens; Tricuspid Valve | 1981 |
Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Enterobacteriaceae Infections; Fermentation; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
New drugs for enteric gram-negative bacillary meningitis in adults.
Topics: Adult; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Meningitis; Meningitis, Haemophilus; Moxalactam | 1981 |
Resistance to cefamandole: a collaborative study of emerging clinical problems.
Topics: Adult; Aged; Bacteroides Infections; beta-Lactamases; Cefamandole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Isoelectric Focusing; Male; Middle Aged; Moxalactam; Penicillin Resistance; Penicillins | 1982 |
The newest cephalosporins: how to use them?
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Moxalactam | 1982 |
[Moxalactam in pediatrics. Clinical and pharmacokinetic experience. Apropos of 37 cases].
Topics: Adolescent; Bacterial Infections; Cephalosporins; Cephamycins; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Kinetics; Male; Meningitis, Haemophilus; Moxalactam; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1983 |
[Chemotherapy of severe bacterial infections in pediatrics].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Clindamycin; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases; Meningitis; Metronidazole; Penicillin G; Pseudomonas Infections; Streptococcal Infections | 1983 |
[Clinical use of new cephalosporins for severe infections in internal medicine].
Topics: Bacteroides Infections; Cefotaxime; Cefoxitin; Cephalosporins; Cross Infection; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Humans; Pseudomonas Infections; Staphylococcal Infections; Structure-Activity Relationship | 1983 |
[In-vitro activity of cefotaxime].
Topics: Cefotaxime; Cefoxitin; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Streptococcal Infections; Streptococcus | 1983 |
Serratia marcescens endocarditis treated with ceftazidime. A case report.
Topics: Adolescent; Ceftazidime; Cephalosporins; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Heart Valve Prosthesis; Humans; Mitral Valve; Serratia marcescens | 1983 |
The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients.
Topics: Adolescent; Adult; Aged; Anaphylaxis; Bacterial Infections; Ceftazidime; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 1983 |
An open study of the use of ceftazidime in Gram-negative infections.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Cystic Fibrosis; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Middle Aged; Osteomyelitis; Pseudomonas Infections; Respiratory Tract Infections; Urinary Tract Infections; Wound Infection | 1983 |
[Comparative bacteriostatic activity of 10 cephalosporins against 100 strains of Serratia].
Topics: Cephalosporins; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Serratia | 1983 |
Use of ceftazidime in the therapy of serious infections, including those due to multiresistant organisms.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Pseudomonas Infections | 1983 |
Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Adult; Aged; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 1983 |
[In vitro activity of a new cephalosporin--cefoperazone--against Enterobacteriaceae and Pseudomonas aeruginosa].
Topics: Cefoperazone; Cephalosporins; Dose-Response Relationship, Drug; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Pseudomonas Infections | 1981 |
Successful treatment of gram-negative bacillary meningitis with moxalactam.
Topics: Adult; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis; Middle Aged; Moxalactam | 1981 |
Hypoprothrombinemia associated with moxalactam treatment of a septic sternoclavicular arthritis due to Citrobacter diversus.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Cephalosporins; Cephamycins; Citrobacter; Enterobacteriaceae Infections; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam; Sternoclavicular Joint | 1981 |
Cefoperazone treatment of experimental endocarditis.
Topics: Animals; Cefamandole; Cefoperazone; Cephalosporins; Cephalothin; Endocarditis, Bacterial; Enterobacter; Enterobacteriaceae Infections; Female; Half-Life; Rabbits; Staphylococcal Infections | 1981 |
Citrobacter meningitis and cerebral abscess in early infancy: cure by moxalactam.
Topics: Brain Abscess; Cephalosporins; Cephamycins; Citrobacter; Enterobacteriaceae Infections; Humans; Infant, Newborn; Male; Meningitis; Moxalactam | 1981 |
Cephalosporin antibiotic agents.
Topics: Bacterial Infections; Cephalosporins; Costs and Cost Analysis; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Meningitis, Haemophilus; Pseudomonas Infections | 1984 |
[New cephalosporins].
Topics: Bacterial Infections; Cephalosporins; Enterobacteriaceae Infections; Female; Gram-Negative Bacteria; Humans; Kinetics; Male; Meningitis | 1984 |
[Gram negative bacilli endocarditis ].
Topics: Adolescent; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Child; Drug Therapy, Combination; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Heart Valve Prosthesis; Humans; Male; Middle Aged; Penicillins; Prognosis; Pseudomonas Infections | 1982 |
[Gram negative infective endocarditis. Apropos of 27 cases].
Topics: Adult; Aged; Brucellosis; Cephalosporins; Child; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Fusobacterium Infections; Haemophilus Infections; Heart Failure; Humans; Male; Middle Aged; Prognosis; Pseudomonas Infections; Shock, Septic | 1982 |
In vivo selection of resistance to multiple cephalosporins by enterobacter cloacae.
Topics: Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 1983 |
[Meningitis and sepsis in the newborn age: therapy concepts and antibiotic therapy].
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Meningitis; Rabbits; Sepsis | 1983 |
Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.
Topics: Adult; Bacteria; beta-Lactamases; Cefamandole; Cefoxitin; Cephalosporins; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Induction; Humans; Male; Microbial Sensitivity Tests | 1980 |
Current concepts in antimicrobial therapy of prostatitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cephalosporins; Chlamydia Infections; Drug Combinations; Enterobacteriaceae Infections; Erythromycin; Humans; Hydrogen-Ion Concentration; Leucomycins; Male; Penicillins; Prostatitis; Sulfamethoxazole; Tetracyclines; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
Microorganisms isolated from peritonsillar abscess and indicated chemotherapy.
Topics: Abscess; Adolescent; Adult; Aged; Cephalosporins; Child; Enterobacteriaceae Infections; Fusobacterium; Fusobacterium Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Middle Aged; Palatine Tonsil; Penicillins; Peptococcus; Peptostreptococcus; Streptococcal Infections; Streptococcus pneumoniae | 1982 |
[Sefril in the treatment of toxic diarrhea in infants].
Topics: Cephalosporins; Cephradine; Diarrhea, Infantile; Enterobacteriaceae Infections; Enterotoxins; Escherichia coli Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Klebsiella Infections; Proteus Infections; Proteus mirabilis; Proteus vulgaris | 1980 |
In vivo inoculum effect and resistance selection with cefamandole and cefoxitin against Enterobacter cloacae in mice.
Topics: Animals; Bacteriological Techniques; Cefamandole; Cefoxitin; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Mice | 1980 |
[Cefuroxime-tobramycin treatment of bacterial infections in cancer patients].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Meningitis, Meningococcal; Neoplasms; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus agalactiae; Tobramycin | 1980 |
Nosocomial pneumonia.
Topics: Aminoglycosides; Cephalosporins; Cross Infection; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillin G; Pneumococcal Infections; Pneumonia; Pseudomonas Infections; Staphylococcal Infections | 1981 |
Effect of combination of cefsulodin and beta-lactam antibiotics against Serratia marcescens.
Topics: Animals; Anti-Bacterial Agents; Cefsulodin; Cephalosporins; Drug Synergism; Enterobacteriaceae Infections; Male; Mice; Mice, Inbred ICR; Serratia marcescens | 1981 |
Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins.
Topics: Amikacin; Cephalosporins; Drug Interactions; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Kanamycin; Microbial Sensitivity Tests | 1982 |
Selection of antimicrobial therapy.
Topics: Anti-Bacterial Agents; Cephalosporins; Child; Enterobacteriaceae Infections; Humans; Osteomyelitis; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Surgical Wound Infection; Vascular Diseases | 1982 |
Cefamandole therapy of endomyometritis following cesarean section.
Topics: Adult; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefamandole; Cephalosporins; Cesarean Section; Endometritis; Enterobacteriaceae Infections; Female; Humans; Postoperative Complications; Pregnancy; Staphylococcal Infections; Streptococcal Infections | 1980 |
Drug trials: treatment of urinary tract infection with multiple-dose intramuscular administration of cephamandole.
Topics: Anti-Infective Agents, Urinary; Cefamandole; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Pain; Staphylococcal Infections; Urinary Tract Infections | 1980 |
Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model.
Topics: Bacterial Infections; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Culture Media; Enterobacter; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus | 1995 |
Enterobacter cloacae in a neonatal intensive care unit: account of an outbreak and its relationship to use of third generation cephalosporins.
Topics: Blood Gas Analysis; Case-Control Studies; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Cross Infection; Disease Outbreaks; Disease Reservoirs; Enterobacter cloacae; Enterobacteriaceae Infections; Equipment Contamination; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; London | 1994 |
Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes.
Topics: Aged; Bacterial Outer Membrane Proteins; beta-Lactamases; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Imipenem; Mutation | 1994 |
Canadian survey of antimicrobial resistance in Klebsiella spp. and Enterobacter spp. The Canadian Antimicrobial Resistance Study Group.
Topics: Anti-Bacterial Agents; Canada; Cefepime; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 1993 |
Antibiotic therapy for enterobacter meningitis: a retrospective review of 13 episodes and review of the literature.
Topics: 4-Quinolones; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Child; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Follow-Up Studies; Humans; Male; Meningitis, Bacterial; Middle Aged; Retrospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
The clinical relevance of Enterobacter infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Drug Resistance; Enterobacter; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Male; Middle Aged; Multicenter Studies as Topic; Prognosis | 1993 |
The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms.
Topics: Adult; beta-Lactamases; Case-Control Studies; Cephalosporins; Citrobacter; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Risk Factors; Serratia marcescens | 1995 |
Escherichia vulneris as a cause of intravenous catheter-related bacteremia.
Topics: Bacteremia; Catheterization, Central Venous; Cefazolin; Cephalosporins; Crohn Disease; Enterobacteriaceae Infections; Equipment Contamination; Escherichia; Female; Humans; Middle Aged; Parenteral Nutrition, Total | 1996 |
Favorable outcome possible in Citrobacter brain abscess.
Topics: Brain Abscess; Cephalosporins; Child, Preschool; Citrobacter; Disease Progression; Enterobacteriaceae Infections; Female; Follow-Up Studies; Humans; Infant; Male; Meningitis, Bacterial | 1996 |
A hospital outbreak of high-level beta-lactam-resistant Enterobacter spp.: association more with ampicillin and cephalosporin therapy than with nosocomial transmission.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Case-Control Studies; Cephalosporins; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Enterobacter; Enterobacteriaceae Infections; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Polymorphism, Restriction Fragment Length | 1996 |
The activity of cefetamet against enterobacterial isolates from community-acquired urinary tract infections.
Topics: Ceftizoxime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Greece; Humans; Lactams; Urinary Tract Infections | 1996 |
Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species.
Topics: beta-Lactam Resistance; Cefepime; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Europe; Humans; Microbial Sensitivity Tests; United States | 1996 |
Bacteremia due to Citrobacter species: significance of primary intraabdominal infection.
Topics: Adolescent; Adult; Aged; Bacteremia; Cephalosporins; Child; Child, Preschool; Citrobacter; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae Infections; Female; Gastrointestinal Diseases; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis | 1996 |
Clostridial endocarditis following penetrating cardiac trauma.
Topics: Adult; Ceftriaxone; Cephalosporins; Clostridium Infections; Diagnosis, Differential; Echocardiography; Endocarditis; Enterobacteriaceae Infections; Escherichia; Heart Injuries; Humans; Male; Wounds, Gunshot | 1997 |
Spontaneous bacterial peritonitis caused by Citrobacter diversus: case report.
Topics: Aged; Alcohol Drinking; Ascites; Cefotaxime; Cephalosporins; Citrobacter; Diagnosis, Differential; Diuretics; Enterobacteriaceae Infections; Fever; Humans; Jaundice; Male; Peritonitis; Spironolactone | 1997 |
Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment.
Topics: Animals; Aztreonam; Ceftazidime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fibrin; Microbial Sensitivity Tests; Monobactams; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Serratia Infections; Serratia marcescens | 1997 |
Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Kidney; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rats; Rats, Wistar | 1997 |
Morganella morganii: a newly reported, rare cause of neonatal sepsis.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Penicillins; Sepsis | 1997 |
Septicemia as a complication of Henoch-Schönlein purpura.
Topics: Ceftriaxone; Cephalosporins; Child; Duodenal Ulcer; Duodenum; Endoscopy, Gastrointestinal; Enterobacter cloacae; Enterobacteriaceae Infections; Follow-Up Studies; Humans; IgA Vasculitis; Injections, Intravenous; Male; Peptic Ulcer Hemorrhage; Sepsis | 1997 |
Rapid emergence of resistance to cefepime during treatment.
Topics: Cefepime; Cephalosporin Resistance; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Hepatitis C; Humans; Liver Abscess; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Failure | 1997 |
Relapsing infection due to Enterobacter species: lessons of heterogeneity.
Topics: Abscess; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Mutation; Pneumonia, Bacterial | 1997 |
Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactamases; Cefotaxime; Cephalosporin Resistance; Cephalosporins; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Poland; Polymerase Chain Reaction | 1998 |
Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Creatinine; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Lung; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rats; Rats, Mutant Strains; Time Factors; Treatment Outcome | 1998 |
An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of gram-negative bacilli.
Topics: Ceftazidime; Cephalosporins; Endotoxins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1998 |
Rapid emergence of resistance to cefepime during treatment.
Topics: Cefepime; Cephalosporin Resistance; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Humans | 1998 |
Control of an outbreak of a highly beta-lactam-resistant Enterobacter cloacae strain in a neonatal special care unit.
Topics: Ampicillin; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Penicillin G; Penicillins; Sweden | 1998 |
Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Imipenem; Injections, Intraperitoneal; Male; Microbial Sensitivity Tests; Pneumonia; Rats; Rats, Wistar; Thienamycins | 1998 |
Molecular characterization of a ceftazidime-resistant Morganella morganii isolate producing a TEM-10 beta-lactamase.
Topics: beta-Lactamases; Ceftazidime; Cephalosporins; DNA, Bacterial; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Molecular Sequence Data | 1999 |
Efficacy of beta-lactam and inhibitor combinations in a diffusion chamber model in rabbits.
Topics: Animals; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Diffusion Chambers, Culture; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Penicillanic Acid; Rabbits; Tazobactam | 1999 |
Emergence of multidrug-resistant Enterobacter cloacae: nosocomial outbreak or change of microbial ecology?
Topics: Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Multiple; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Retrospective Studies | 1999 |
[Kluyvera cryocrescens: a positive urine culture in a young girl with persistent proteinuria].
Topics: Bacteriuria; Cefuroxime; Cephalosporins; Child; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Prodrugs; Proteinuria | 1999 |
Biliary complications after orthotopic liver transplantation in rats.
Topics: Animals; Bile Ducts; Biliary Tract Diseases; Cefazolin; Cephalosporins; Enterobacteriaceae Infections; Liver Transplantation; Necrosis; Opportunistic Infections; Penicillins; Piperacillin; Rats | 1999 |
Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Imipenem; Infection Control; Intensive Care Units; Paris | 1999 |
ampR gene mutations that greatly increase class C beta-lactamase activity in Enterobacter cloacae.
Topics: Amino Acid Sequence; Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Ceftazidime; Cephalosporin Resistance; Cephalosporins; DNA, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Mutation; Plasmids; Sequence Analysis, DNA | 2000 |
Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.
Topics: Bacterial Typing Techniques; beta-Lactamases; Cefpirome; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Fatal Outcome; France; Humans; Imipenem; Male; Microbial Sensitivity Tests; Thienamycins; Trachea; Urine | 2000 |
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Half-Life; Imipenem; Kidney Diseases; Male; Meropenem; Penicillinase; Pneumonia, Bacterial; Protein Binding; Rats; Rats, Wistar; Thienamycins; Uranyl Nitrate | 2000 |
[Bacteremia caused by Enterobacter cloacae: emergence of antibiotic resistance after antibiotic prophylaxis].
Topics: Aged; Aged, 80 and over; Antibiotic Prophylaxis; Aortic Aneurysm, Abdominal; Bacteremia; Cefamandole; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Male; Pneumonia, Bacterial; Postoperative Complications | 2000 |
[Hafnia alvei septicemia revealing pyocholecystitis complicated by liver abscess in an immunocompetent patient].
Topics: Acute Disease; Aged; Bacteremia; Cefepime; Cephalosporins; Cholangiography; Cholangiopancreatography, Endoscopic Retrograde; Cholecystectomy; Cholecystitis; Enterobacteriaceae Infections; Gentamicins; Hafnia alvei; Humans; Liver Abscess; Male; Netilmicin; Suppuration; Treatment Outcome | 2000 |
Leclercia adecarboxylata peritonitis in a child receiving chronic peritoneal dialysis.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Child, Preschool; Enterobacteriaceae Infections; Escherichia; Gentamicins; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis; Peritonitis | 2000 |
Intra- and inter-generic plasmid-mediated spread of cephalosporin and aminoglycoside resistance amongst Klebsiella aerogenes K41 and other enterobacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacter aerogenes; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Plasmids | 2001 |
Clinical and molecular epidemiology of chromosome-mediated resistance to third-generation cephalosporins in Enterobacter isolates in eastern France.
Topics: Cephalosporins; Cohort Studies; DNA Fingerprinting; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; France; Humans; Incidence; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Risk Factors | 2000 |
Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Cefepime; Cefpirome; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Child; Cloning, Molecular; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Protein Structure, Secondary; Recombinant Proteins; Sequence Deletion | 2001 |
[Nosocomial enterobacter - sepsis in neonatal intensive care unit in Pleven].
Topics: Bulgaria; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Female; Humans; Hygiene; Incidence; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Pregnancy; Retrospective Studies; Sepsis; Workforce | 2000 |
Efficiency of cefepime in postoperative meningitis attributable to Enterobacter aerogenes.
Topics: Adolescent; Arnold-Chiari Malformation; Cefepime; Cephalosporins; Enterobacter aerogenes; Enterobacteriaceae Infections; Humans; Meningitis, Bacterial; Neurosurgical Procedures; Postoperative Complications | 2001 |
Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins.
Topics: Analysis of Variance; Bacterial Infections; Brazil; Cephalosporins; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Infant, Newborn; Infection Control; Inservice Training; Intensive Care Units, Neonatal; Prospective Studies; Risk | 2001 |
Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp.
Topics: Bacteremia; Cephalosporin Resistance; Cephalosporins; Cohort Studies; Drug Utilization; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Risk Factors | 2001 |
Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Internal Medicine; Logistic Models | 2001 |
Carriage of Staphylococcus aureus and of gram-negative bacilli resistant to third-generation cephalosporins in cirrhotic patients: a prospective assessment of hospital-acquired infections.
Topics: Adult; Aged; Carrier State; Cephalosporin Resistance; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; France; Hospital Units; Humans; Liver Cirrhosis; Male; Middle Aged; Nasal Cavity; Prevalence; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Urine | 2001 |
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Statistics as Topic; Sulbactam | 2001 |
Long-Term outcome of neonatal Citrobacter koseri (diversus) meningitis treated with imipenem/meropenem and surgical drainage.
Topics: Carbapenems; Cefotaxime; Cephalosporins; Citrobacter; Combined Modality Therapy; Drainage; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Meningitis, Bacterial; Prognosis; Treatment Outcome | 2001 |
Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China.
Topics: beta-Lactamases; Blotting, Southern; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; China; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Genes, Bacterial; Humans; In Situ Hybridization; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
Clinical features and antimicrobial susceptibility trends in Citrobacter freundii bacteremia.
Topics: Adult; Aged; Aminoglycosides; Bacteremia; Cephalosporins; Citrobacter freundii; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Male; Microbial Sensitivity Tests; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2002 |
Cefotaxime and nephrotoxicity.
Topics: Cephalosporins; Drug Evaluation; Enterobacteriaceae Infections; Humans; Kidney; Sepsis; Urinary Tract Infections | 1979 |
Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
Topics: Animals; Cefamandole; Cefoxitin; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Haemophilus influenzae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Staphylococcus aureus | 1978 |
[Increasing incidence of Serratia marcescens bacteraemia in intensive care patients (author's transl)].
Topics: Adolescent; Adult; Aged; Austria; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Humans; Intensive Care Units; Middle Aged; Retrospective Studies; Sepsis; Serratia marcescens | 1978 |
Therapy of serious infections with cefamandole.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefamandole; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Sepsis; Staphylococcal Infections; Streptococcal Infections | 1978 |
[Progress in antibacterial chemotherapy].
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cephalosporins; Cephalothin; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Proteus Infections; Pseudomonas Infections | 1978 |
Cefamandole nafate therapy of respiratory tract, skin, and soft tissue infections in 74 patients.
Topics: Adult; Bacterial Infections; Cefamandole; Cellulitis; Cephalosporins; Enterobacteriaceae Infections; Enterococcus faecalis; Haemophilus Infections; Humans; Pneumococcal Infections; Respiratory Tract Infections; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes | 1978 |
Treatment of obstetric and gynecologic infections with cefamandole.
Topics: Abscess; Acute Disease; Bacterial Infections; Bacteroides Infections; Cefamandole; Cellulitis; Cephalosporins; Cesarean Section; Clostridium Infections; Endometritis; Enterobacteriaceae Infections; Female; Genital Diseases, Female; Humans; Hysterectomy; Peptococcus; Peptostreptococcus; Peritonitis; Pregnancy; Streptococcal Infections; Surgical Wound Infection; Vulvitis | 1979 |
Antibiotics in pyelonephritis.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Proteus Infections; Pseudomonas Infections; Pyelonephritis | 1979 |
[Clinical evaluation of cefamandole in pediatric surgery (author's transl)].
Topics: Bile Ducts; Cefamandole; Cephalosporins; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Humans; Infant; Male; Postoperative Complications | 1979 |
[Cefuroxim resistance of pathogenic strains isolated in a pediatric environment].
Topics: Bacteria; Cefuroxime; Cephalosporins; Child, Preschool; Drug Resistance, Microbial; Enterobacteriaceae Infections; Gentamicins; Humans; Infant; Microbial Sensitivity Tests | 1979 |
Comparison of cefazedone with cefazolin and cephalothin in treatment of experimental infections in mice.
Topics: Animals; Bacterial Infections; Cefazolin; Cephalosporins; Cephalothin; Enterobacteriaceae Infections; Female; Male; Mice; Mice, Inbred ICR; Staphylococcal Infections; Streptococcal Infections | 1979 |
Cefamandole in treatment of peritonitis.
Topics: Adult; Aged; Bacterial Infections; Bacteroides Infections; Cefamandole; Cephalosporins; Child, Preschool; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Peritonitis; Staphylococcal Infections | 1978 |
Clinical experience with cefamandole for treatment of serious bone and joint infections.
Topics: Adolescent; Adult; Aged; Arthritis, Infectious; Bacterial Infections; Bacteroides Infections; Bursitis; Cefamandole; Cephalosporins; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Osteomyelitis; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Surgical Wound Infection | 1978 |
Carbenicillin plus cefamandole in the treatment of infections in patients with cancer.
Topics: Adolescent; Aeromonas; Aged; Bacterial Infections; Carbenicillin; Cefamandole; Cephalosporins; Corynebacterium Infections; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Flavobacterium; Humans; Listeriosis; Male; Middle Aged; Neoplasms; Respiratory Tract Infections; Sepsis; Tobramycin | 1978 |
Cefamandole in the treatment of infections due to Enterobacter and indole-positive Proteus.
Topics: Adult; Aged; Cefamandole; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Infant; Male; Middle Aged; Proteus Infections; Pyelonephritis; Skin Ulcer; Surgical Wound Infection; Urinary Tract Infections | 1978 |
Cephalosporin-aminoglycoside synergism in experimental enterococcal endocarditis.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Drug Synergism; Endocarditis, Bacterial; Enterobacteriaceae Infections; Half-Life; Male; Rabbits; Time Factors | 1976 |
Urinary infections in total hip arthroplasty. Influences of prophylactic cephalosporins and catheterization.
Topics: Arthroplasty; Cephalosporins; Enterobacteriaceae Infections; Female; Hip; Humans; Male; Pseudomonas Infections; Surgical Wound Infection; Urinary Catheterization; Urinary Tract Infections | 1976 |
[1st Spanish epidemic of plasmid resistance to 3d generation cephalosporins: the implication of SHV-2].
Topics: Bacterial Proteins; beta-Lactamases; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Incidence; Microbial Sensitivity Tests; R Factors; Spain; Species Specificity | 1992 |
Antibiotic-resistant Enterobacter and the newer cephalosporins.
Topics: Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans | 1992 |
Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model.
Topics: Animals; Cefepime; Ceftazidime; Cephalosporins; Citrobacter freundii; Disease Models, Animal; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia Infections; Serratia marcescens; Virulence | 1992 |
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Sepsis | 1991 |
New beta-lactams: new problems for the internist.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans | 1991 |
Significance of inducible cephalosporinase remaining in the experimentally infected rat granuloma pouch after beta-lactam therapy.
Topics: Animals; Anti-Bacterial Agents; Cephalosporinase; Cephalosporins; Culture Media; Drug Evaluation, Preclinical; Enterobacteriaceae Infections; Enzyme Induction; Exudates and Transudates; Granuloma; Male; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Serratia marcescens | 1991 |
[Cephalosporins in the treatment of urinary tract infections].
Topics: Cephalosporins; Drug Evaluation; Enterobacteriaceae Infections; Humans; Pseudomonas Infections; Urinary Tract Infections | 1990 |
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections | 1990 |
L-658,310, a new injectable cephalosporin. III. Experimental chemotherapeutics and pharmacokinetics in laboratory animals.
Topics: Animals; Bacterial Infections; Ceftazidime; Cephalosporins; Diabetes Mellitus, Experimental; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Gentamicins; Half-Life; Isoindoles; Macaca mulatta; Male; Mice; Neutropenia; Pseudomonas Infections | 1989 |
Conservative management of renal carbuncles in children.
Topics: Adolescent; Ampicillin; Carbuncle; Cephalosporins; Child; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Kidney Diseases; Tomography, X-Ray Computed | 1989 |
beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Outer Membrane Proteins; beta-Lactamases; Cephalosporinase; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Enzyme Stability; Hydrolysis; Microbial Sensitivity Tests | 1989 |
Prior antimicrobial therapy and resistance of Enterobacter Citrobacter and Serratia to third generation cephalosporins.
Topics: Cephalosporins; Citrobacter; Cross Infection; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Serratia marcescens | 1988 |
Clinical consequences of development of resistance to third generation cephalosporins.
Topics: Adolescent; Adult; Aged; Cephalosporins; Child; Citrobacter; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Immune Tolerance; Klebsiella; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens | 1987 |
[Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins].
Topics: Adult; Aged; beta-Lactamases; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Mutation; Sepsis | 1985 |
Enterobacter cloacae bacteremia: clinical analysis of 41 cases.
Topics: Adult; Cephalosporins; Cross Infection; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Sepsis | 1988 |
In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefpodoxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Chemical Phenomena; Chemistry; Enterobacteriaceae Infections; Escherichia coli Infections; Hexosyltransferases; Klebsiella Infections; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Proteus Infections; Staphylococcal Infections; Streptococcal Infections | 1987 |
Comparison of resistance types in Enterobacter cloacae 1977 and 1985.
Topics: Ampicillin Resistance; beta-Lactamases; Carbenicillin; Cephalosporins; Drug Resistance, Microbial; Drug Utilization; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Penicillin Resistance; R Factors | 1987 |
Reduction of cephamycin concentrations at the infection site in mice with experimental peritoneal infection caused by cephalosporinase-producing bacteria.
Topics: Animals; Ascitic Fluid; beta-Lactamases; Cefazolin; Cefmetazole; Cefoxitin; Cephalosporinase; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Enterobacter; Enterobacteriaceae Infections; Male; Mice; Mice, Inbred ICR; Peritonitis; Proteus Infections; Proteus vulgaris | 1986 |
Concurrent oral surgery and orthopaedic treatment in the multiply injured patient: is there an increased incidence of orthopaedic sepsis?
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Child; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Orthopedics; Postoperative Complications; Premedication; Staphylococcal Infections; Streptococcal Infections; Surgery, Oral; Surgical Wound Infection; Wounds and Injuries | 1987 |
Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy.
Topics: Aged; Anti-Bacterial Agents; Cardiac Surgical Procedures; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Mutation | 1986 |
[In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
Topics: Cefotaxime; Cefoxitin; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Moxalactam; Species Specificity | 1986 |
Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit.
Topics: Cephalosporins; Disease Outbreaks; Drug Resistance, Microbial; England; Enterobacter; Enterobacteriaceae Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal | 1987 |
Enterobacter mediastinitis following cardiac surgery.
Topics: Cardiac Surgical Procedures; Cephalosporins; Disease Outbreaks; Enterobacter; Enterobacteriaceae Infections; Humans; Male; Mediastinitis; Middle Aged; New Mexico; Postoperative Complications; Prospective Studies; Surgical Wound Infection | 1985 |
Third generation cephalosporins.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Infant, Newborn | 1985 |
Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 1985 |
Second-generation cephalosporins.
Topics: Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans | 1985 |
Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Enterobacter; Enterobacteriaceae Infections; Humans; Kanamycin; Penicillin Resistance; Polymyxins; Streptomycin; Tetracycline; Urinary Tract Infections | 1969 |
Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
Topics: Boston; Cephalosporins; Cross Infection; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae Infections; Feces; Female; Gentamicins; Hospitals, General; Humans; Infant; Infant, Newborn; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Pigmentation; Polymyxins; Respiratory Tract Infections; Serotyping; Serratia marcescens; Species Specificity; Sputum; Urinary Tract Infections; Urine; Wounds and Injuries | 1970 |
Bacteriologic and epidemiologic characteristics of Enterobacter hafniae and Enterobacter liquefaciens.
Topics: Adolescent; Adult; Aged; Ampicillin; Carbenicillin; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Infant; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Nalidixic Acid; Polymyxins; Respiratory Tract Infections | 1971 |
["Velocef squibb" in the treatment of respiratory and urinary infections (author's transl)].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cephalosporins; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Proteus Infections; Respiratory Tract Infections; Urinary Tract Infections | 1973 |
Comparison of the chemotherapeutic and pharmacodynamic activities of cephradine, cephalothin, and cephaloridine in mice.
Topics: Animals; Cephaloridine; Cephalosporins; Cephalothin; Cyclohexanes; Enterobacteriaceae Infections; Female; Mice; Microbial Sensitivity Tests; Staphylococcal Infections | 1973 |
Cefoxitin, a semisynthetic cephamycin antibiotic: in vivo evaluation.
Topics: Animals; Biological Assay; Carbamates; Cephalosporins; Drug Evaluation; Enterobacteriaceae Infections; Female; Methyl Ethers; Probenecid | 1974 |
The treatment of bacterial cystitis, comparing cephalexin with sulfisoxazole.
Topics: Cephalosporins; Cystitis; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Proteus Infections; Staphylococcal Infections; Sulfisoxazole | 1971 |
[Sensitivity to antibiotics of 1,531 strains of enterobacteria].
Topics: Algeria; Ampicillin; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Colistin; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Furazolidone; Gentamicins; Humans; Kanamycin; Klebsiella; Penicillin Resistance; Proteus; Salmonella; Salmonella typhi; Streptomycin; Tetracycline | 1971 |
The newer antibiotics: some therapeutic considerations.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Cephalexin; Cephaloglycin; Cephalosporins; Enterobacteriaceae Infections; Gentamicins; Humans; Pseudomonas Infections; Rifampin; Staphylococcal Infections | 1972 |
Clinical and in vitro evaluation of cephapirin: a new parenteral cephalosporin.
Topics: Adult; Aged; Bacterial Infections; Cellulitis; Cephalosporins; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Humans; Infusions, Parenteral; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 1972 |
Antibiotics 1971.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Catheterization; Cephalosporins; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Lincomycin; Mycoses; Penicillins; Pregnancy; Sepsis; Staphylococcal Infections; Umbilicus | 1971 |
Cephalexin: clinical and laboratory studies.
Topics: Adult; Aged; Bacterial Infections; Bacteriuria; Cephalosporins; Child; Cystitis; Enterobacteriaceae Infections; Female; Humans; Male; Methods; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Pyelonephritis; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections | 1971 |
[Treatment of bacterial infections with cephalexin].
Topics: Adult; Animals; Cephalosporins; Dogs; Drug Hypersensitivity; Drug Resistance, Microbial; Enterobacteriaceae Infections; Humans; Infant; Mice; Microbial Sensitivity Tests | 1971 |
CIBA 36278-Ba" chemotherapy and toxicology in laboratory animals.
Topics: Animals; Cephalosporins; Cephalothin; Dogs; Enterobacteriaceae Infections; Evaluation Studies as Topic; Guinea Pigs; Injections, Intravenous; Lethal Dose 50; Male; Mice; Mice, Inbred Strains; Pyelonephritis; Rabbits; Rats; Rats, Inbred Strains; Urinary Tract Infections | 1970 |
Recent advances in chemotherapy.
Topics: Bacteroides Infections; Cephalosporins; Drug Therapy; Enterobacteriaceae Infections; Haemophilus Infections; Humans; Lincomycin; Penicillins; Pneumococcal Infections; Pseudomonas Infections; Staphylococcal Infections | 1968 |
In vitro and in vivo evaluation of cephalexin.
Topics: Bacteriuria; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests | 1968 |
Laoratory appraisal of cephalexin.
Topics: Ampicillin; Animals; Cephaloridine; Cephalosporins; Enterobacteriaceae Infections; Humans; Mice; Microbial Sensitivity Tests; Staphylococcal Infections | 1968 |